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INTRODUCTION
  
 INTRODUCTION 
The Siddha system or the traditional tamil system of medicine is one of the ancient medical systems of 
the world contemporaneous with those of the Egyptian, Mesopotamian and Grecian medicines. The 
distinctiveness of Siddha system is evident by its continuous service to the humanity for more than 5000 years in 
combating diseases. More than a medical system, it encompasses a way of healthy life. It deals with whole subject 
of life in its various branches. 
This system is built around the tenets of the moral wisdom, scientific knowledge, doctrine and philosophy, 
astrology, astronomy, alchemy, yoga, science of rejuvenation etc. This system is based on the eternal wisdom 
(Siddhis) practiced by the eighteen Siddhars who received this Siddha science, expressive of the perfect wholeness 
of cosmic consciousness through doctrine, introspection and meditation. The Siddhars are described as Arivan 
(the knowledgeable) in Tholkappiam the olden book of tamil grammer. 
This noble Siddha system relies on the five natural elements (Earth, Water, Fire, Air and Space). The 
natural combination with each other forms the basis of three humours of the body namely Vatham (Air and Space), 
Pitham (Fire), Kabam (Earth and Water). The diagnosis in this system depends on Eight ways of examination 
(Envagai thervu) such as Naadi, Sparisam, Naa, Niram, Mozhi, Vizhi, Malam and Moothiram. Any derangement 
in this three humours results in disease. 
Ulcer (Pun) is defined as discontinuity of skin tissue in any part of the body. According to Siddhar aruvai 
maruthuvam Silai pun is the ulcer mainly occurs in the blood vessels, nerves and in between the muscle fibres. 
Initially it occurs as small papulo-vesicular eruptions. There are five types of Silaipun ( Vali, Azhal, Iyam, 
Mukkutram and Enbu silaipun). 
Silaipun may be correlated with varicose ulcer in modern science. The varicose ulcer is one of the late 
manifestations of chronic venous insufficiency of the lower limbs, a disease of great importance to public health 
due to its high incidence, prevalence and the high socio-economic impact that it brings, since it is difficult to treat 
and requires prolonged work absenteeism. Chronic venous insufficiency may be classified as a syndrome that 
includes from telangiectasia to active ulcers, originating in chronic venous hypertension caused by venous 
obstruction or reflux, with or without muscle pump insufficiency. 
The extrapolated prevalence rate of varicose vein in india providing warning is about 47,928,177 in 
statistics. According to another estimate 15 to 20% of population in india is suffering vein disease. 
Patients who have asymptomatic varicose veins can simply be reassured. The treatment of Varicose ulcer 
varies from simple elevation of the affected limb to surgery, including grafts and various types of dressings. 
Though limb elevation is simple, it accelerates the healing process of the ulcer. But it can’t be followed by patients 
 all the time when they are not bedridden. Skin grafts have strict indications and can only be performed in 
specialized centers. Varicose vein Surgery is only indicated in patients with a predominance of superficial venous 
system insufficiency. 
 “Elathy Chooranam” and “Pathirasara Virana Puchu Thailam” were one among the Siddha medicines. 
“Elathy Chooranam” as Internal medicine (Reference: Siddha Vaithiya Thirattu) - and “Pathirasara 
Virana Puchu Thailam” as External medicine (Reference: Theraiyar Thaila Varuka Churukam) were selected for 
treating Silaipun patients as most of the ingredients of trial drug have wound healing property.   
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 AIM AND OBJECTIVE: 
AIM: 
The purpose of this trial is to evaluate the therapeutic efficacy of Siddha herbal drug “Elathy chooranam” 
(Internal ) and “Pathirasara virana poochu thailam” (External) in the treatment of Silaipun (Varicose ulcer). 
OBJECTIVE:  
PRIMARY OBJECTIVE:   
❖ To evaluate the therapeutic efficacy of Siddha drugs “Elathy chooranam” (Internal) and “Pathirasara 
virana poochu thailam”(External) in reducing pain, itching, oozing and healing of Varicose ulcer 
(silaipun).  
SECONDARY OBJECTIVE:   
❖ To study the Siddha basic principles like Envagai thervu, Elu udal thathukal, Neerkuri Neikuri in varicose 
ulcer (Silaipun) patients.  
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SIDDHA  ASPECT 
Synonym: 
Naadi viranam, Narambu kiranthi pun. 
Definition: 
Naadi or vein is a vessel which carries the blood from a system of minute tubes termed 
capillaries to the heart. 
Naadi viranam is defined as inflammation of vein. Initially it appears as a small papular 
or papulo-vesicular eruption in the superficial skin surface.  
Pun is defined as discontinuity or break in a bodily membrane that impedes the organ 
of which that membrane is a part from continuing its normal function. 
The papular or papulo-vesicular eruption arise in the area congested with varicose vein 
and affects the surrounding structures which later penetrates deep into the bone and 
appears as spider web. Hence, named Silaipun. 
Types of Silaipun: 
There are five types of Silaipun. They are 
1. Vali Silaipun 
2. Pitha Silaipun 
3. Iyya Silaipun 
4. Mukkutra Silaipun 
5. Enbu Silaipun 
Vali silaipun: 
The symptoms of vali silaipun are frothy blackish red discharge from the ulcer which 
increased at night time and also have severe pain. 
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Pitha silaipun: 
The symptoms of Pitha silaipun are burning ulcer, excessive thirst, foul smelling 
yellowish pus and bloody discharge occurs at day time. 
Iyya silaipun: 
There is a shiny indurated lesion which bursts and oozes the pus. They also have severe 
itching. 
Mukkutra silaipun: 
It is an incurable type and have the symptoms of all vali, azhal and iyya silaipun. 
Enbu silaipun: 
The inflammation of the vein, supplies the bone results in papulovesicular eruption. It 
bursts and oozes the bloody pus oozes. It is an incurable type.  
Aetiology of ulcer: 
“பயில்  ம ொழியரீ்  திரேகத்தில்  கிரு ிதொரே 
பேந்துதிரி  குட்டம்ரபொல்  புள்ளி  கொணும்  
 யலதுவும்  கிரு ியுந்தொன்  நடந்து  புக்கில் 
ர ேியது  சேசமேேமெடித்து  புண்ணொம்”.                                                
          – குருநொடி 
According to text Siddhar aruvai maruthuvam, causes of ulcer are 
• Derangement of three humours 
• Abscess 
• Trauma 
• Burns 
• Insect bite 
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According to text agathiyar rana vaithiyam, causes of ulcer are 
• Derangement of three humours 
• Trauma 
According to T.V.Sambasivam pillai dictionary, causes of ulcer are 
• Idiopathic 
• Traumatic 
Classification: 
According to text Siddhar Aruvai maruthuvam, 
• Dhusta viranam – 15 
• Adhusta viranam – 45 
Other classification: 
➢ Based on the derangement of three humours, ulcer is classified into 
  Vali pun 
      Azhal pun 
      Iyya pun 
      Vali iyya pun 
      Pitha iyya pun 
      Mukkutra pun 
      Kuruthi pun 
      Kuruthi thee pun 
      Kuruthi vali pun 
      Kuruthi iyya pun 
      Kuruthi vali iyya pun 
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      Kuruthi vali pitha pun 
      Kuruthi pitha iyya pun 
      Kuruthi Mukkutra  pun 
      Velutha kuruthi pun 
According to T.V.Sambasivam pillai dictionary, various types of ulcer are 
➢ Neruppu pun (Burns) 
➢ Mega pun (Venereal ulcer) 
➢ Vellai pun (Gonorrheal ulcer) 
➢ Aaraa pun (Chronic ulcer) 
➢ Kiranthi pun (Syphilitic secondary rashes) 
➢ Ottu pun (Contagious sore) 
➢ Kuzhi pun (Deep sore or perforating ulcer) 
➢ Rasa pun (Diabetic carbuncle) 
➢ Karappan pun (Eczematous ulcer) 
➢ Parangi pun (Syphilitic primary sore) 
➢ Vettu pun (Incised wound) 
➢ Kaya pun (Traumatic sore) 
➢ Azhi pun (Sloughing sore) 
➢ Koruku pun (Chancre) 
➢ Veditha pun (Fissurel ulcer) 
➢ Azhar pun (Inflamed ulcer) 
➢ Rasa vekkadu pun (ulcer caused by mercurial poisioning) 
➢ Vayitru pun (Gastric ulcer) 
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➢ Thulai pun / Purai pun (Sinus) 
➢ Ari pun (Rodent ulcer) 
According to T.V.Sambasivam pillai dictionary, Ulcer is also classified into 
➢ Saruma pun (Dermatitis) 
➢ Athirvu pun (Dermatitis traumatica) 
➢ Thee pun (Dermatitis calorica) 
➢ Kulirchi pun (Chill blains or frost bite) 
➢ Azhugu pun (Dermatitis gangrenosa) 
➢ Nanju pun (Dermatitis medicamentosa) 
➢ Veppu noi pun (Exanthema) 
➢ Thinavu pun (Pruritis and urticaria) 
➢ Kirandhi (Venereal ulcer) 
➢ Korukku pun (Chancroid) 
Classification and symptoms of ulcer according to text Siddhar aruvai 
maruthuvam, 
• Vali pun ilakkanam: 
The characteristic features of vali pun are black, red or white in colour,  purulent 
discharge and pricking pain. 
• Azhal pun ilakkanam: 
Azhal pun is characterized by acute onset, yellow, red, dark or pale red coloured 
ulcer, clear discharge, pain, burning sensation and redness. 
• Iyya pun ilakkanam: 
Iyya pun have the symptoms of pricky pain, pale coloured ulcer and discharge 
which is sticky in nature. 
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• Vali pitha pun ilakkanam: 
It is characterized by pricking pain, redness, dryness, clear and scanty discharge 
with foul smell. 
• Vali iyya pun ilakkanam: 
It is characterized by rough, heavy and hard lesion, itching, pricking pain and 
scanty discharge which is sticky in nature. 
• Pitha iyya pun ilakkanam: 
It is characterized by hot, itching, burning sensation, pain, pale in colour and 
discharge which is sticky in nature. 
• Mukkutra pun ilakkanam: 
It has the symptoms of vatha, pitha and kaba ulcer. 
• Kuruthi pun ilakkanam: 
It is characterized by red or coral like colour, very painful, bloody discharge. 
Symptoms of these ulcers is similar to dhusta viranam. 
• Kuruthi vali pun ilakkanam: 
It is characterized by roughness, pricking pain, blood stained discharge and red 
coloured ulcer.  
• Kuruthi pitha pun ilakkanam: 
The ulcer is red and yellow in colour. The discharge is clear and blood stained. 
• Kuruthi iyya pun ilakkanam: 
It is characterized by red colour ulcer, swelling, itching and bloody discharge. 
• Kuruthi vali pitha pun ilakkanam: 
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It has the mixed features of both kuruthi vali pun and kuruthi pitha pun. 
 
• Kuruthi vali iyya pun ilakkanam: 
It has the mixed features of both kuruthi vali pun and kuruthi iyya pun. 
• Kuruthi pitha iyya pun ilakkanam: 
It has the mixed features of both kuruthi pitha pun and kuruthi iyya pun. 
• Kuruthi mukkutra pun ilakkanam: 
It has the mixed features of both kuruthi vali pun, kuruthi pitha pun and kuruthi 
iyya pun. 
• Velutha kuruthi pun ilakkanam: 
The ulcer is pale red in colour, centrally elevated, shiny and not have any 
discharge. 
According to Agasthiyar rana vaidhyam, viranam is classified into Dhusta viranam, 
Adhusta viranam and Sutha ratha viranam. 
1.Dhusta viranam is further classified into 4 subtypes, 
➢ Dhusta vaatha viranam: The ulcer is black and white in colour. The ulcer may 
be deep seated and penetrating the bone. The is a purulent discharge and 
pricking pain present around the ulcer. 
➢ Dhusta pitha viranam: It is characterized by reddish white or yellow coloured 
ulcer of acute onset, clear discharge, burning sensation and pain present around 
the ulcer. 
➢ Dhusta silethuma viranam: It is characterized by raised ulcer, itching, 
pricking pain and discharge which is sticky in nature. 
➢ Rathavatha dhusta viranam: It is characterized by bright red or coral like 
coloured ulcer and bloodstained discharge. 
2. Adhusta viranam: 
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The ulcer having purulent pus and bloody discharge. It is easily curable.  
 
3. Sutha ratha viranam: 
It is characterized by centrally elevated papular lesion and reddish black in 
colour. 
According to text Anubava vaidhya deva ragasiyam, the types of Sathiya viranam are 
I)  Krishta viranam:  It is a non-healing ulcer with bleeding caused by trauma. 
II) Avakartha viranam: It is a perforating and deep-seated ulcer. 
III) Vichinna viranam: It is a ulcer look like cut wound 
IV) Piravilambi viranam:  The ulcer which looks like cut wound may be deep seated 
and penetrating the bone. 
V) Nibaathika viranam: In this type, bone exposed in centre of the ulcer is surrounded 
by necrotized tissue. 
VI) Vitha viranam: It is a traumatic ulcer caused by stones. 
VII) Pinna viranamm: It is an ulcer caused by sword, knife like sharp instruments. 
VIII) Vithalitha viranam: It is an ulcer caused by pressure applied over bleeding area 
and also have joint pain. 
According to text Virana karappan roga sigitchai, 
• Nija viranam: 
It occurs spontaneously due to derangement of three humours. 
• Aaganthuga viranam 
It is caused by violent trauma. 
• Dhusta viranam: 
The symptoms of Dhusta viranam are  
➢ Open or closed ulcer, 
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➢ Extensive softness or hardness present, 
➢ Surrounding skin may be very cold or hot and pigmented, 
➢ Purulent discharge, 
➢ Intolerable pain, swelling and itching. 
• Sutha viranam 
The features of Sutha viranam are 
➢  Pale colour and soft ulcer. 
➢ There is no evidence of hyperpigmentation, pain, pus discharge 
and  warmth. 
 According to text Agasthiyar rana vaithiyam, Common sites of ulcer are 
➢ Thol (skin) 
➢ Iraichi (muscle) 
➢ Peru narambu (arteries and veins) 
➢ Siru narambu (capillaries) 
➢ Keel (joints) 
➢ Elumbu (bone) 
➢ Vayiru (abdomen) 
➢ Marmasthanam (genital organs) 
According to text Virana karappan sigitchai, Common sites of ulcer are 
➢ Thol (skin) 
➢ Virai (blood vessels) 
➢ Mamisam (muscle) 
➢ Thasai naar (tendon) 
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➢ Santhigal (joints) 
➢ Elumbu (bone) 
➢ Kudalgal (GIT) 
➢ Marmasthanangal (sirasu-head, hirudhayam-heart,           siruneer 
pai - urinary bladder) 
Curable and incurable conditions: 
“புண்ணும்  மெளுத்து  நீர் ிகுந்து  ரபொதக்குத்துெலி   ிகுந்தொல் 
உண்ம ப்படரெ  மசங்கலங்கள்  யிேத்த ொகிற்  தீேொது 
நன்ேிக்கீழொய்ச்  சீழ்ெிழுந்து  பின்மேநமேக்குஞ்  மசம்புண்ரண”  
                                           -அகத்தியர் 2000 (மூன்றொம் பொகம்) 
According to text Agasthiyar 2000 (III part), 
➢ The features of curable condition are having ulcer with pale 
coloured margin, oozing, pricking pain and formation of 
granulation tissue. 
➢ The features of non-healing condition are having ulcer with pus 
discharges and no formation of granulation tissue. 
According to text Siddhar Aruvai Maruthuvam, the Curable and incurable conditions 
depends on the 
➢ Age of affected person 
➢ Shape of the ulcer - oval, triangle and rectangular ulcers are 
easily curable 
➢ Ulcer in eye, nostrils, gums, chest, nipple and joints are difficult 
to treat 
➢ Ulcer in diabetes, TB, leprosy and syphilis are non-healing ulcer 
➢ Improper medication may delay the healing process 
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➢ Ulcer with pus discharge, raised floor, fissure and deep wound 
are not curable 
➢ Ulcer in vertex finger tip, vital points (varmam), deep seated 
wound which penetrate the bone and bone marrow are not 
curable  
According to text Virana karappan sigitchai, the features of easily curable wound are 
➢ Ulcer in healthy adults 
➢ Shape of the ulcer is circular or oval 
➢ The edges of the ulcer are clean 
➢ Ulcer in male genitalia, lips, buccal cavity and cheeks. 
According to text Virana karappan sigitchai, causes of delayed wound healing are 
➢ Inflammation of tendon with pus discharge 
➢ Surgical removal of blood vessels 
➢ Deep seated ulcers 
➢ Secondary infection in ulcers 
➢ Fracture of bones 
➢ Improper removal of foreign particles 
➢ Toxic bite induced ulcer 
➢ Improper medication 
➢ Irritation of wound by any other object 
➢ Stress 
➢ Alcoholism 
➢ Abnormal sleeping pattern 
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Siddha Pathology 
According to Siddha system of medicine five elements (Earth, Water, Fire, Air 
and Space) of nature combined with each other and forms the basis of three humours 
of the body, namely Vali (Vatham), Azhal (Pitham) and Iyyam (Kabam). Whenever 
there is derangement in this three humours, the resultant is the disease. Vatham is 
responsible for all physiological and biological activities of the body. The blood vessels 
which contain stagnant blood get dilated, coiled and become more prominent. After that 
inflammatory process occurs at the site due to derangement of Pitham. The deranged 
Pitham simultaneously leads to derangement of Vatham and Kabham which is 
responsible for the formation of ulcer in the affected part of the body. 
Piniyari muraimai (Diagnostic methods) 
Piniyari muraimai is the method of diagnosing disease. It is based on following 
principles 
➢ Poriyal arithal 
➢ Pulanal arithal 
➢ Vinaathal 
Poriyal arithal and Pulanal arithal means examining the patients Pori and Pulan with 
that of physicians Pori and Pulan. 
Imporikal  
➢ Mei (skin) 
➢ Vai (tongue) 
➢ Kan (eyes) 
➢ Mooku (nose) 
➢ Sevi(ear) 
Impulan 
➢ Osai (sound) 
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➢ Ooru (sensation) 
➢ Oli (vision) 
➢ Suvai (taste) 
➢ Naatrum (smell) 
Vinaathal 
Vinaathal is a method of enquiring about the details of the patient’s problem from his 
own words or from his parents or attenders who are taking care of the patients when the 
patient is not able to speak or if the patient is the child. 
ENVAGAI THERVUGAL: 
“தேணியிலுள்ள  ெியொதிதன்மே  யட்டொங்  கத்தொல் 
தொேறிய  ரெண்டுெது  ரயரதொ  மென்ேில் 
திேணியரதொர்  நொடிகண்கள்  சத்தத்  ரதொடு 
ரதகத்திேது  பரிசம்  ெருணம்  நொக்கு 
இேண ல  மூத்திே ொ  ிமெக  மளட்டும் 
இதம்படரெ  தொன்பொர்த்துக்  குறிப்புங்  கண்டு 
பேணருளொல்  மபரிரயொர்கள்  பொதம்  ரபொற்றிப் 
 பண்புதெறொ ல்  பண்டிதஞ்  மசய்ெரீே”.  
                                                – குணெொகட நொடி 
Naadi (pulse) 
In pun the following typs of naadi could be felt. They are 
➢ Iyya naadi  
➢ Vadhakaba naadi 
ஐய நொடி: 
  “தொேமுள்ள   ரசத்து ந்தொ   ேிளகில்   மெப்பு 
சய ீமள  இரு ல் ந்  தொே  கொசம் 
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ஈமளமுறுஞ்  சந்நிெிட  ரதொடம்  ெிக்கல் 
இருத்ரேொகங்  கேப்பொன்  ெிேண  ரதொடம்”. 
                                     – சதக நொடி  
ெொத ிகுதியுடன் சீதளம் ரசர்ந்தொல்: 
“இருக்கு ந்த  ெொதத்தில்  ரசத்து ஞ்  ரசர்ந்தொல் 
இமளப்பிரு ல்  ெிடசந்நி  ரதொடம்  ெசீ்சு 
 ருக்கின்ற  குளிர்கொய்ச்சல்  ெிேண  ரதொடம்”      
                                                  -சதக நொடி 
 
Sparisam -  test sensation, temperature and nature of the skin 
Naa  - test the color of saliva, color of sputum and nature of speech 
Niram  -  test the variation in pigmentation of skin  
Mozhi  - Vadham (normal pitch) 
   Pitham (high pitch) 
   Kabham (low pitched) 
   Thontham (mixed all the above) 
Vizhi  -  Vadham (black in color, increased lacrimation) 
   Pitham (yellow or red in color) 
   Kabham (white in colour) 
Malam -  Vadham (stools are in color and constipated) 
   Pitham (yellowish white in color) 
   Kabham (white in color) 
   Thontham (mixed color) 
 
Moothiram- 
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Collection of urine for the determination of Neerkuri and Neikuri is an 
important diagnostic method. 
 
Neerkuri 
“ெந்தநீர்க்  கரிஎமட  ணம்நுமே  எஞ்சமலன் 
மறந்திய  லுளெமெ  யமறகுது  முமறரய”                                                                      
              -ரதேர்  நீர்க்குறி  மநய்க்குறி  நூல் 
Prior to the day of urine examination, the patient is instructed to take a balanced 
diet the patient should have good sleep. After waking up in the morning, the first urine 
voided is collected in a clear wide mouthed glass container and is subjected to analysis 
of Neerkuri within one and half an hour. 
Neikuri: 
The collected specimen (urine) is kept open in a glass dish or china clay 
container. It is to be examined under direct sunlight without any shaking of the vessel. 
Then add one drop of gingelly oil without disturbing the urinary specimen and 
the Neikuri was noted in direct sunlight and concluded the diagnosis as follows 
Character of vadha neer: 
“அேமெே  நீண்டிேஃரத  ெொதம்” 
When the oil drop lengthens like a snake, it is called vadha neer. 
Character of pitha neer: 
“ஆழி  ரபொற்பேெின்  அஃரத பித்தம்” 
When the oil drop spreads like a ring, it is called pitha neer. 
Character of kabha neer: 
“முத்மதொத்து  நிற்கின்  ம ொழிெமதன்  கபர ” 
When the oil drop appears like a pearl, it is called kabha neer. 
Character of thontha neer: 
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“அேெிலொழியும்  ஆழியில்  அேவும் 
அேெின்  முத்தும்  ஆழியில்  முத்தும் 
ரதொயிற்றில்  மதொந்த  ரதொடங்க  ளொர ”. 
Snake in the ring, ring in the snake, snake in the pearl and ring in the pearl are the 
characters of thontha neer. 
Line of treatment: 
“ரநொய்நொடி  ரநொய்முதேொடி  யதுதணிக்கும் 
ெொய்நொடி  ெொய்ப்பச்  மசயல்”. 
Thiruvalluvar says in thirukural about physician’s duty to study the disease, study the 
cause, seek subsiding ways and do what is proper and effective. 
“உற்றென்  தீர்ப்பொன்  ருந்துமழச்  மசல்ெொமேன் 
றப்பொேற்  கூற்ரற  ருந்து”.             
In Siddha system of medicine, the main aim of the treatment is to cure the udalpini and 
mana pini. 
Treatment is not only for prefect healing but also for prevention and rejuvenation. In 
Siddha system of medicine line of treatment are as follows 
➢ Neekam (Treatment) 
➢ Niraivu (Rejuvenation) 
➢ Kaapu (Prevention) 
Neekam (Treatment) 
• Viresanam: 
“துகின்ற  லக்கட்மட  மயொழிய  மெத்தொல் 
உடலிலுள்ள  ெொமதமயலொ  ம ொடுங்கிப் ரபொகும்”. 
Siddha system of medicine is based on three humours and hence the treatment is 
mainly aimed to bring the three humours to equilibrium state and thereby restoring the 
physiological condition of the seven thathus. 
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• Internal medicine: 
The medicine which are taken internally are called as internal medicines. These are 
classified into 32 types. E.g. Surasam, Chaaru, Pittu, Vadagam and Chooranam. 
• External medicine: 
The medicines which are applied externally are called as external medicines. These 
also classified into 32 types. Eg. kattu, pattru, ottradam, vedhu, thokkanam. 
According to text sinthamanni- Gandharuvathathai ilambagam-324 management of 
wound described as follows. 
When there is a traumatic injury in the body the following treatments and therapies can 
be followed  
“மநய்க்கிழி  மெக்கப்பட்டொர்  மநய்ப்பத்தல்  கிடத்தப்பட்டொர் 
புக்குழி  எஃகம்நொடி  இரும்பிேொல்  ரபொழப்பட்டொர் 
முது ேப்மபொந்துரபொல  முழும ய்யும்  புண்களுற்றொர்க்கு 
இது  ருந்மதன்ே  நல்லொர்  இழுதுரசர்  கெளம்மெத்து”. 
                           -(சிந்தொ ணி   கொந்தருெதத்மத   இலம்பகம்   324) 
1.Nei kizhi:  
A cloth bundled with herbs, which is soaked with heated medicated oil and 
given fomentation. 
2.Ennai patharil kidathal: 
 The affected person is made to lie down into a tub filled with medicated oil. 
3.Removal of foreign particles:  
When there is a foreign particle at the site of wound like iron or any other 
metallic object, it is cut and cleaned as per procedure. 
 4.Application of medicines 
5. Covering the wound:  
The wound is covered with a small carpet made out of rat hair. 
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• Anubanam 
“அனுபொேத்தொரல  யெிழ்தம்  பலிக்கும் 
இேிதொே  சுக்குஇஞ்சி –  பிேிமுதுகொல் 
ரகொ யம்பொல்  முமலப்பொல்  ரகொமநய்ரதன்  மெற்றிமலநீர் 
ஆ ிமதயொ  ேொய்ந்து  மசய்யலொம்”.                 
• Pathiyam (Dietary regimen): 
“பத்தியத்திேொரல  பலனுணண்டொகும்  ருந்து 
பத்தியங்கள்  ரபொேொல்பலன்  ரபொகும்  பத்தியத்தில் 
பத்தியர   மெற்றி தரும்  பண்டிதர்க்கு  ஆதலிேொல் 
பத்தியர   உத்திமயன்று  பொல்”. 
- ரதமேயர் மெண்பொ 
In mild conditions of the disease, salt and tamarind can be taken in little quantities. 
When the condition is severe, tamarind should be avoided and salt must be consumed 
after frying. 
Niraivu (Rejuvenation): 
Substance used for neutralizing the three humours are 
“ஒன்றிய  ெொதபித்த  கப ிமெ  யுயேொெண்ணம் 
நன்றது  கறிகமளல்லொம்  நொளுர   சம ப்பேொய்ந்ரதொர் 
தின்றிடு  ிளகு  ஞ்சள்  சீேகமுயர்ந்த  கொயம் 
மென்றிமகொள்  சுக்ரகொரடலம்  மெந்தயமுள்ளி  ரசர்த்ரத”. 
- பதொர்த்த குணசிந்தொ ணி 
 
The patients are well motivated. The nature and course of the disease is explained to 
them.  Lifestyle modification adviced. 
Kaapu (Prevention): 
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Ideal measures mentioned in the Siddha classical text Pathartha guna cinthamani for 
healthy living as below, 
“திண்ண ிேண்டுள்ரள  சிக்க  ெடக்கொ ற்  
மபண்ணின்பொ  மலொன்மறப்  மபருக்கொ ல்  உண்ணுங்கொல் 
நீர்சுருக்கி  ர ொர்மபருக்கி  மநய்யுருக்கி  யுண்பெர்தம் 
ரபருமேக்கிற்  ரபொர   பிணி”. 
 
“ஆறுதிங்கட்  மகொருதடமெ  ெ ே ருந்  தயில்ரெொம் 
           அடர்நொன்கு  திக்மகொருகொற்  ரபதியுமற  நுகர்ரெொம் 
ரதறு தி  மயொன்றமேக்ரகொர்  தேநசியம்  மபறுரெொம் 
              திங்களமேக்  கிேண்டுதேஞ்  செேெிருப்  புருரெொம் 
ெறீுசதுர்  நொட்மகொருகொல்  மநய்முழுக்மகத்  தெிரேொம் 
                 ெிழிகளுக்குஞ்  சேமூன்று  நொட்மகொருகொ   லிடுரெொம் 
நொறுகந்தம்  புட்ப ிமெ  நடுநிசியில்  முகரேொம் 
                   ந ேொர்க்கிங்  ரகதுகமெ  நொ ிருக்கு  ிடத்ரத”. 
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MODERN ASPECT 
STRUCTURE OF SKIN 
                  The skin is a protective covering of the body. It, with all its specialized 
derivatives, makes up what is called the integument (Latin: a covering) which covers 
the entire surface of the human body. 
                    The human skin shows wide regional variations in structure like scalp, 
face, ear lobes, back, palms and soles etc. Thickness varies; the number of sebaceous 
glands, collagen fibre and vasculature differ in different parts of the integument. 
 The skin consists of three layers 
❖ EPIDERMIS (superficial epithelial layer) 
❖ DERMIS or CORIUM (connective tissue layer) 
❖ HYPODERMIS or subcutaneous layer. 
Structure of Epidermis 
                 The epidermis is formed of non-vascular stratified epithelium. Its usual 
thickness is between 0.07mm and 0.12mm. But in certain parts, like the soles of the feet 
and the palms of the hand, it is very thick, ranging from 0.8mm to 1.4mm. 
                  The following are the main layers of the epidermis which can be made out 
microscopically in a section perpendicular to the skin surface. 
1.Stratum germinativum. 
                   This is the deepest portion of the epidermis and is composed of columnar 
cells placed perpendicular to the skin surface. The whole of the epidermis germinates 
from this stratum hence the name “stratum germinativum”. 
2.Stratum malpighii or the prickle cell layer. 
                     It is superficial to the basal cell layer and is composed of several layers of 
polyhedral cells, connected to each other by intercellular bridges. 
3.Stratum granulosum. 
                    It is superficial to the stratum malphigii. It is composed of flat, fusiform 
cells which are one to three layers thick. These cells contain irregular granules of 
keratohyalin and lysosomal enzymes and cystine rich proteins. 
4.Stratum lucidum. 
                     Superficial to the stratum granulosum is the pale, wavy-looking layer 
known as stratum lucidum. 
 5.Stratum corneum. 
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                  This is the most superficial layer, the outer surface of which is exposed to 
the atmosphere. It consists many layers of non-nucleated, flattened, cornified cells. 
6.Dendritic cells of epidermis. 
                  These are melanocytes, langerhans cells and indeterminate cells.  
Structure of dermis (cutis vera or corium) 
                    Dermis is profusely supplied with blood vessels. Dermis is divided into 
papillary and dermis. It contains connective tissue fibres, cells and all dermal 
appendages. Connective tissue is formed by three main components  
                     1.Collagen fibres 
                     2.Elastic fibres 
                     3.Ground substance. 
Epidermal appendages: 
1. Sebaceous glands 
2. Sweat glands: There are of two types 
❖ Eccrine glands 
❖ Apocrine glands 
3. Hair 
4. Nails          
Physiology 
The skin performs a multitude of functions. These are 
1.Protective function: 
❖ It protects against sunlight by synthesis of melanin pigment. 
❖ The stratum corneum has been held as barrier to penetration. 
2.Sense organ: 
                The skin is richly supplied with nerves and various types of specialized 
sensory end organs, which provide information regarding environmental changes. 
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3.Secretion and excretion: 
               The skin possesses various types of glands which pour secretions on the 
surface. The more important ones are the sweat and the sebaceous glands.the important 
substances excreted in it are sodium chloride, sodium phosphate, sodium bicarbonate, 
keratin and a small amount of urea.  
4. Body Heat Regulation: 
                The skin plays the most important role in the regulation of heat loss. It loses 
heat to the external environment in three ways by conduction by radiation and by 
evaporation. 
5.Storage functions of skin: 
❖ Fat is laid down in fat cells as a permanent store of subcutaneous adipose tissue. 
This provides the reserve stores of body energy. 
❖ Blood is stored in the rich subpapillary plexuses of the dermis. 
❖ The skin is also a good storehouse of ergosterol 
6.Absorption: 
                   Skin can absorb substances dissolved in fatty solvents like vitamins and 
hormones. this is the principle behind the local application and massaging of various 
ointments, salves and creams dissolved in animal fats. 
7.Gaseous exchange through skin: 
                 A small amount of gaseous exchange occurs through the skin. 
VARICOSE ULCER 
    Synonyms – Post thrombotic ulcer, Gravitional ulcer 
    Definition; 
         Venous ulcer also known as stasis ulcer is the most common aetiology of lower 
extremity ulceration. Venous ulceration results from increased pressure in the venous   
system of the lowerlimb. Most common cause is insufficiency of the valves in the deep 
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venous system and lower perforating veins of the lower leg. This mostly occurs in the 
age of 40 to 60 years. 
    Epidemiology; 
          The extrapolated prevalence rate of varicose vein in india providing warning is 
about 47,928,177in statistics. According to another estimate 15 to 20% of population 
in india is suffering vein diseases.  
           Despite being more common in elderly persons, with a peak of prevalence in 
individuals aged between 60 and 80 years, 22% of those affected are approximately  40 
years of age ,while 13% develop VU before they reach 30 years of age, evidencing the 
losses that this disease causes in work production. Of all lowerlimb ulcers 
approximately 70 to 80 % are caused by CVI. 
           The first venous stasis ulcer episode occurs in average, five years after the 
diagnosis of CVI and in patients with VU, 47% have already had two or more ulceration 
episodes, whereas 21% of them have already had six or more episodes.The annual 
recurrence  rate  varies  from 33 to 42%.In general , 60% of the ulcers remain for a 
period of 6 months or longer, and over 40% of them persist for more than one The mean 
duration is 6  to 7 months, varying   from 4 weeks to 72 years.   
  Varicose vein; 
            Incompetence of valves      – Sapheno – femoral junction (SFJ) 
                                                        -Sapheno – popliteal junct 
                                                         -Perforator  
            Reflux in superficial veins    - long sphenous vein (LSV) 
                                                           -Short saphenous vein (SSV) 
                Reflux in deep vein           - Femoral vein  
-Popliteal vein  
  Classification of causes; 
              Primary                                   - congenital  
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              Secondary                                - pregnancy 
                                                                -Ascites  
                                                                -Obesity  
                                                               -  Constipation  
                                                                - Thrombosis of leg veins  
                                                                 - Spend long period of time standing 
Predisposing factors;  
Old age 
Obesity 
Female 
Pregnancy 
Hypertension 
Lower socio – economic status 
Previous injury 
H / O Deep vein thrombosis 
Congestive heart failure 
Anaemia 
                                         Zinc deficiency 
                                         Defective fibrinolytic system 
Classification; 
A) Clinical                       C0 :  No visible or palpable sings of venous disease 
                                            C1 :  Telengiectasies or reticular vein 
                                            C2   :  Varicose veins 
                                            C3  :  Oedema 
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                                            C4 :   Pigmentation or oedema, lipodermatosclerosis 
                                             C5 :  Healed venous ulcer 
                                              C6 :  Active venous ulcer 
                                                    -primary  
                                                    -Secondary 
    B) Anatomic                           - Superficial veins  
                                                    -Perforator veins  
                                                    -Deep veins 
Pathophysiology: 
            Venous blood from lower limb are pumped into heart through various factors, 
one of the main factor is calf muscle pumping. With each contraction of the calf, blood 
should be pumped to the heart (muscle pump). Intact valves in the lower leg are required 
to prevent this pumped blood from reflexing out through the perforators in to the 
superficial system. The hypertrophy of these superficial veins is marked by the 
development of varicose veins. Increased pressure on the iliac veins from pregnancy or 
obesity or simple inactivity may also result in the appearance of venous insufficiency 
as well. The valvular insufficiency results in disorder in the venous and capillary 
circulation in the leg. Valvular insufficiency may occur from prior thrombophlebitis or 
congenital weakness. 
  On physical examination: 
➢ Varicose vein can be of any shape and size. 
➢ The edges are slopping and pale purple - blue in colour. 
➢ The margin is thin and blue of growing epithelium. 
➢ The floor is formed by pale granulation tissue. 
➢ The ulcer is usually shallow and flat never penetrates the deep fascia. 
➢ The discharge is seropurulent with occasional trace of blood. 
➢ The base of the ulcer is fixed to the deeper structures. Granulation tissue and 
fibrin present in base of the ulcer. 
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➢ The surrounding skin is shows signs of chronic venous hypertension 
(pigmentation, induration and tenderness). 
➢ Venous dermatitis with hyperpigmentation and hemosiderosis or haemoglobin 
deposition in the skin. 
➢ There may be scare of previous ulcer. 
➢ Regional lymph nodes (inguinal nodes) are only enlarged if the ulcer infected. 
➢ Lower extremities varicosities present. 
➢ Swelling of lower limb 
➢ Lipodermatosclerosis with thickening and fibrosis of normal adepose tissue 
under skin. 
Complications: 
➢  Cellulitis 
➢  Osteomyelitis 
➢  Malignant changes 
➢  Hemorrhage 
➢  Perioseitis 
DIFFERENTIAL DIAGNOSIS: 
                Traumatic ulcer – this ulcer can be caused by either mechanical, physical or 
chemical injury.  This ulcer heels quickly unless supervened by infection or ischaemia. 
Which may turn this ulcer to chronicity.  
                Ischaemia or arterial ulcer – thus ulcer due to peripheral arterial diseases 
and poor peripheral circulation.  This is more often seen in older people and younger 
men between 20 to 40 yrs. In this ulcer patches of dry gangrene may be present along 
with ulcer. These ulcers are occurs on the anterior and outer aspect of the leg, dorsum 
of hand, on the toes or the heel. Pain is main complaint of this disease. An arterial ulcer 
occurs below the medial malleolus. There is history of intermittent claudication and 
resting pain in majority of cases. If the leg is kept elevated above the heart level the 
ulcer shows no sign of healing and patient will complaint of pain in this position.  On 
examination these ulcers are punched out with destruction of deep fascia. Tendons, 
bones, and underlying joints may be exposed on the floor of the ulcer. Which covered 
by minimal granulation tissue.  Presence of ischaemic changes can be detected on the 
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foot (pallor, dry skin, loss of hair, fissuring of nails). Pulse of dorsalis pedis artey this 
always either feeble or absent. 
               Trophic ulcer (neurogenic)- these ulcers have punched out edge with slough 
in the floor thus resembling a gummatous ulcer.  Eg bed sore and perforating ulcers. 
These ulcers develop as the result of repeated trauma to the in sensitive part of the body.  
These ulcers are commonly seen on the heel and the ball of the foot. When the patient 
is ambulatory, on the buttock and on the back on the heel the patient is  non-ambulatory.  
The ulcer starts with callosity under which suppuration takes place, the pus comes out 
and the central hole forms the ulcer which gradually burrows through the muscles and 
tendons to the bone. Floor is covers with offensive slough and tendons and even bones 
can be seen here. The surrounding skin has no sensation. The cause may be spinal or 
leprosy or peripheral nerve injury, diabetic neuropathy, tabes dorsalis, transeverse 
myelitis or meningomyelocele.   
                Tuberculous ulcer – this mostly result from bursting of caseous lymphnodes 
are from absees from bone and joint tuberculosis and breaks out on the surface. Ulcer 
is slightly painful usually seen in the neck and groin. The features of ulcer is its edge 
which is thin, reddish blue and determined, pale granulation tissue with scanty 
serosanguineous discharge in the floor and slight induration at the base. The regional 
lymphnodes are enlarged, nontender and matted.  
                   Syphilitic ulcer – hard chancre appears on the external genitalia 3 to 4 
weeks after infection in the first stage of this disease.  It is painless and possesses a 
characteristic indurated base which feels like a button. Lymphnodes are enlisted. Extra 
genitalia chancres which are seen in the nipple, lip, tongue and anal canal are nit often 
not indurated.  
                   Meleny's ulcer- these ulcers are seen the postoperative wounds either after 
the operation for perforated viscus or for drainage of emphyema thoracis. This type of 
ulcer is due to symbiotic action of micro aerophilic non haemolytic streptococci and 
haemolytic staphylococcus aureus.  It is a gangrenous wound following any operation. 
Rarely is it seen on the leg or on the dorsum of the hand.  It is spreading ulcer which is 
painful with signs of toxaemia.  The floor contains aboundent foul smelling granulation 
tissues with copious seropurulent discharge.  It is surrounded by deep purple zone, 
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which in turn is surrounded by an outer zone of erythema. This particular condition is 
painful, toxaemic and the general condition deteriorates without treatment. If it is not 
treated the patient’s general condition deteriorates and he will die ultimately.   
Examination: 
➢ Abdomen mass 
➢ Peripheral pulses 
➢ Pattern of varicosities – LSV/SSV 
➢ Trendelenburg test  
Investigation: 
➢ Doppler 
➢ Air plethysmography – venous refiling time 
➢ Venogram 
➢ Duplex scan 
➢ USG abdomen /pelvis 
➢ Ulcer- swab culture, TWDC 
Treatment: 
A) Non-surgical.     compression stockings 
                          wound dressing 
                          Weight reduction 
Leg elevation at rest 
B) Surgical       High saphenous ligation 
Endovenous laser ablation 
Sclerotherapy 
 
Prevention: 
➢ Be active moving the leg muscles keeps the blood flowing 
➢ Keep your blood pressure under control.  Work with your doctor 
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➢ To temporarily relieve symptoms, lie down and raise your legs at least six inches 
above the level of your heart. Do this for ten minutes a few times each day 
➢ Maintain a normal body weight  
➢ Wear prescription compression stockings as specified by your doctor  
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DRUG REVIEW 
INTERNAL MEDICINE - ELATHY CHOORANAM 
  ELAM 
          Botanical name : Elettaria cardamomum 
          English name  : Cardamom seeds 
          Family   : Zingiberaceae 
Organoleptic character 
           Taste   : Acrid 
           Potency  :   Hot 
           Division  : Acrid 
General properties: 
                “மதொண்மட  கொல்கவுள்  தொலுகுங்ளில் 
                              ரதொன்றும்  ரநொதிசொம்பன் - ர கத்தொல் 
                உண்மட  ரபொல்எழுங்  கட்டிகிரிச்சொேம் 
                               உழமல  ெொந்திசிலந்தி  ெிஷஞ்சுேம் 
                பண்மட  மெக்மகெிதொகரநொய்  கொசமும் 
                               பொழுஞ்   ரசொ ப் பிணி  ெிந்துநட்டமும் 
                ஆண்மட  யமீளென் பித்தம்   இமெக்மகல்லொம் 
                              ஆல  ொங்க ழ்  ஏல ருந்தரத”. 
Action: 
• Stimulant 
• Carminative 
• Stomachic 
• Antispasmodic 
• Tonic 
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Chemical constituents: 
                   Alpha terpinyl acetate, Linalyl acetate, Limonen, Linalorl, Cineole, 
Citrinellol, Nerol, Transnerolidol      
CHUKKU 
Botanical name : Zingiber officinale 
           English name  : Dried ginger 
            Family  : Zingiberaceae 
Organoleptic character 
            Taste   : Acrid 
            Potency  :   Hot 
            Division  : Acrid 
General properties: 
“சூமல ந்தம்  மநஞ்மசரிப்பு  ரதொடர ப்  பம் ழமல 
மூலம்  இமேப்பிரு ல்  மூக்குநீர்  – ெொதகப 
ரதொட தி  சொேந்  மதொடர்ெொத  குன் நீர்த் 
ரதொடம்ஆ  ம்ரபொக்குஞ்  சுக்கு”. 
                                     -அகத்தியர் குணெொகடம் 
Action: 
• Stimulant 
• Stomachic 
• Carminative 
Chemical constituents: 
                 Gingerin, Phellandrane, High flavonoid contents, polyphenols, tannin, 
isovanilin, adenine 
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KOOGAINEERU 
     Botanical name : Maranta arunsinace 
            English name  : Arrow root 
            Family  : Marantaceae 
Organoleptic character 
           Taste   : Sweet 
           Potency  :   Hot 
           Division  : Sweet 
General properties: 
             “ர ேியிடும்  ெொய்க்கு  ிருதுெொம்  ஆக்கியுண்ணத் 
தொேிரு ல்  மெப்பதிக  தொக ிமெ  – ஏேிருக்கும் 
அம்ரப  றிளங்கிழங்கி  தியொெர்க்கு  ொ ணப்பூங் 
மகொம்ரப  கூமகக்கிழங்மகக்  கூறு”. 
- அகத்தியர் குணெொகடம் 
Action: 
➢ Refrigerant 
➢ Demulcent 
➢ Nutrient 
THALISAPATHIRI 
   Botanical name : Taxus buccata 
            English name  : English yew 
            Family  : Taxaceae 
Organoleptic character 
           Taste   : Acrid 
           Potency  :   Hot 
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           Division  : Acrid 
General properties: 
“நொசி  களப்பிணிகள்  நொட்பட்ட  – கொசஞ்சு 
ெொசம்  அருசி  ெே ங்கொல்  – ெசீீெரு 
ர க ந்தம்  அத்திசுேம்  ெிட்ரடகுந்  தொளிசத்தொல் 
ஆகுஞ்  சுகப்பிேச  ெம்”. 
                          -அகத்தியர் குணெொகடம் 
Action: 
➢ Carminative 
➢ Stomachic 
➢ Expectorant 
➢ Tonic 
SIRUNAAGAPOO 
   Botanical name : Mesua nagassarium 
            English name  : Ceylon lorn wood 
            Family  : Calophyllaceae 
Organoleptic character 
           Taste   : Bitter, astringent 
           Potency  :   Coolent 
           Division  : Acrid 
General characters: 
“சிறுநொகப்   பூெிேதுமசய்  மகதமேச்  மசொல்ரெொம் 
குறியொகும்  ர கத்மதக்   மகொல்லும்  – மநறிெிட்டுத் 
தீதொய்ச்  மசல்ெொயுமெந்  தீர்க்கு ிகு   ற்ரபொக்கு  
ரகொதொய்!  இமதயறிந்து  மகொள்”. 
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Action: 
➢ Astringent 
➢ Carminative 
➢ Anti – inflammatory  
➢ Anti pyretic 
MILAGU 
   Botanical name : Piper nigrum 
            English name  : Black pepper 
            Family  : Piperaceae 
Organoleptic character 
           Taste   : Bitter, Acrid 
           Potency  :   Hot 
           Division  : Acrid 
மபொதுகுணம்: 
“தீயொகி  மயங்கும்  திரியு மத  யொெத்து 
ர ொயொ   மலப்படியு  முண்டொக்கொற்  – பொயொது 
ரபொந்தி ிர்ெொ  தங்கிேந்தி  புண்ணரீும்  ண்ணெர்க்கும் 
கொந்திம ய்ெொ  தச்சலுப்மபக்  கொய்”. 
Action: 
➢ Carminative 
➢ Pungent 
➢ Anti periodic 
➢ Analgesic 
➢ Anti inflammatory 
➢ Anti oxidant 
➢ Cyclo oxygenase inhibitory activity 
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Chemical constituents: 
                  A volatile alkaloid piperine or pipirine 5-9%, piperidine or piperidin 5%, 
balsamic volatile essential 1-2%, fat 7%. Mesocarp contains chavicin, a balsamic 
volatile oil, starch, gum, piperrettine, pipericide, sarmentine, eugenol. 
                 Ref: Indian Herbal Pharmacopoeia,0-321. 
KIRAMBU 
   Botanical name : Syzygium aromaticum 
            English name  : Cloves, Clove tree 
            Family  : Myrtaceae 
Organoleptic character 
           Taste   : Acrid 
           Potency  :   Hot 
           Division  : Acrid 
மபொது குணம்: 
“பித்த  யக்கம்  ரபதிமயொடு  ெொந்தியும்ரபொம் 
சுத்தெிேத்தக்  கடுப்புந்  ரதொன்றுர ொ - ம த்த 
இலெங்கங்  மகொண்டெ ருக்ரகற்  சுக ொகும் 
 ல ங்ரக  சுட்டும ே  ெொழ்த்து”. 
- அகத்தியர் குணெொகடம் 
Action: 
➢ Anti spasmodic 
➢ Carminative 
➢ Stomachic  
Chemical constituents: 
             Essential oils mainly contain euginol, euginyl acetate, beta – caryophiline. 
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SUGAR 
   Botanical name : Saccharum officinarum 
            English name  : Sugar cane 
            Family  : Poaceae 
Organoleptic character 
           Taste   : Sweet 
           Potency  :   Coolent 
           Division  : Sweet 
மபொது குணம்: 
“சீேிச்  சர்க்கமேத்  தீேொத  ென்சுேமுங் 
கூேிக்கும்  ெொதத்தின் கூட்டுறவும்  – ஏேிருக்கும் 
ெொந்தி  மயொடுகிரு ி  ொறொத  ெிக்கலுர  
ரபொந்திமசமய  ெிட்டுப்  புேண்டு”. 
                                              -அகத்தியர் குணெொகடம் 
Action: 
➢ Antiseptic 
➢ Demulcent 
 EXTERNAL MEDICINE - PATHIRASARA VIRANA POOCHU 
THAILAM 
AVARAI  
   Botanical name : Cassia auriculata 
            English name  : Tanners - cassia 
            Family  : Caesalpiniaceae 
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Organoleptic character 
           Taste   : Astringent 
           Potency  :   Coolent 
           Division  : Sweet 
General properties: 
“ர ொகத்தி  ேொரல ெிமளந்தசலம்   மெட்மடயேல் 
ஆகத்தின்  புண்ரணொ  டருங்கிேொணி  – ரபொகத்தொன் 
ஆெொமேப்  பஞ்சகங்மகொள்  அத்திசுேம்  தொகமும்ரபொம் 
ஏெொமேக்  கண் ட   ொரத!” 
Action: 
➢ Astringent 
➢ Tonic 
Chemical constituents 
                                       Bark contains tannin 25p.c and ash 5p.c 
VEMBU    
   Botanical name : Azadiracta indica 
            English name  : Neem 
            Family  : Meliaceae 
Organoleptic character 
           Taste   : Bitter 
           Potency  :   Hot 
           Division  : Acrid 
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General properties: 
“கிரு ிகுட்ட  ொந்தங்  மகடுெிடஞ்சு  ேங்கள் 
மபொரு ிய  சூரிமகயின்  புண்கள்  – ஒரு ிக்க 
நிம்பத்  திமலயிருக்க  நீடுலகில்  நீங்கொ ல் 
கம்பத்  திமலயிருக்கக்  கொண்”. 
Action: 
➢ Stimulant 
➢ Anthelmintic 
➢ Discutient 
Chemical constituents: 
                                       Active principle is a light yellow non-crystalline, better, 
resinous substance without alkaloidal properties. Sugar is present and tannin occurs in 
the outer portion of bark.  Activity resides in the liber or inner bark. 
NAAYURUVI               
Botanical name : Achyranthus aspera 
            English name  : Prickly chaff 
            Family  : Amaranthaceae 
Organoleptic character 
           Taste   : Bitter, Astringent, Pungent   
           Potency  :   Hot 
           Division  : Acrid 
General properties: 
“ லிகொேங்   மகப்புள்ள அப ொர்க்கி   யின்ரெேொல்   
ெசியமுண்டொம் 
இமலமூல   உதிே ந்தம்   ரபதிகபம்ெியர்வுதந்தி   
யிறங்குர கம் 
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 மலரயறும்   படிபுரியு முள்ளரிசி   பசி ொற்றும்   
ெமசமூலம் 
பல ொதர்க்   குள்ளழுக்மக நீக்குெங்கஞ்   சிந்தூேம்   
பண்ணு ொரதொ”. 
Action: 
➢ Astringent 
➢ Diuretic 
➢ Alterative 
➢ Anti periodic 
Chemical constituents: 
   Fruits contains a large percentage of alkaline ash containing potash. 
VETPALAI           
   Botanical name : Wrightia tinctoria 
            English name  : Sweet indrajoo 
            Family  : Apocynaceae 
Organoleptic character 
              Taste   : Astringent, sweet, slightly bitter 
           Potency  :   Hot 
           Division  : Acrid 
General properties: 
“அக்கிேிமய   மெத்திருக்கு   ொந்தெொதம்   ரபொக்குந் 
திக்குழரி    ரதொடத்மதத்   தீர்த்துெிடும்  - மசொர்க்கெிரு 
கட்பொமலக்   கூற்மறமெத்த   கொே ட   யிரல! 
மெட்பொமல   நன் ருந்தொம்   ெிள்”. 
Action: 
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➢ Astringent 
Chemical constituents: 
                             The bark contains triterpenes as the major components and B 
sitosterol as a minor component. The former included B-amyrin, lupeol and another 
triterpene alcohol. 
PARUTHI 
     Botanical name : Gossypium herbaceum 
            English name  : Indian cotton plant 
            Family  : Malvaceae 
Organoleptic character 
           Taste   : Astringent, sweet 
           Potency  :   Hot 
           Division  : Acrid 
General properties: 
“பருத்தியிமல   ம ொக்கிேண்மடப்   பொலிலமேத்   துண்ண 
ெருந்துகின்ற   ர கம ல்லொம்   ொறும்   – பருத்த 
ெிேத்தபித்தத்   ரதொடு  ெிேணெகீ்   கம்ரபொம் 
அேத்தெிதழ்   ொரத!   யமற”. 
Action: 
➢ Astringent 
➢ Tonic 
Chemical constituents: 
     Querdetin, betaine, choline, salicylic acid etc. oil determinations made on the whole 
seeds of G. herbaceum varieties found in the following places, were as follows:- 
a) Surat                    moisture 5.10 to 9.90; oil 16.70 to 18.80 
b) Surti broach         moisture 5.10 to 9.90; oil 21.65 
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c) Goghari E.5         moisture 5.10 to 9.90; oil 16.25 
d) Dharwar               moisture 5.10 to 9.90; oil 18.15. 
PULI                
   Botanical name : Tamarindus indica 
            English name  : Tamarind 
            Family  : Caesalpiniaceae 
Organoleptic character 
           Taste   : Sour 
           Potency  :   Hot 
           Division  : Acrid 
General properties: 
“அழுபுண்மண    நீக்கும் அடல்  ரசொமப    ொற்றும் 
எழுபொண்டு   மெப்ரபொக்கும்   இப்பொல்  - முழுதும் 
அேியச்   சிெந்தகண்ரணொ   யொற்றுங்   கேலொம் 
புளியிமலமய   நன்றொய்ப்   புகல்”. 
Action: 
➢ Stimulant 
Chemical constituents: 
   Pulp contains tartaric acid 5p.c., citric acid 4 p.c., malic and acetic acids, tartaric of 
potassium 8p.c., invert sugar 25 to 40p.c., gum and pectin. Seeds testa contain a fixed 
oil and insoluble matter. Seeds contain albuminoids, fats, carbohydrates 63.22 p.c., 
fibre and ash containing phosphorus and nitrogen. Fruit contains trace of oxalic acid. 
THUTHUVALAI 
   Botanical name : Solanum trilobatum 
            English name  : Purple fruited pea egg plant 
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            Family  : Solanaceae 
Organoleptic character 
           Taste   : Slightly bitter, pungent 
           Potency  :   Hot 
           Division  : Acrid 
General properties: 
“கொது ந்தம்   கொமதழுச்சி   கொசந்   திேவு தம் 
ஓது ந்த    முத்ரதொடம்   உட்சூமல   – தொதுநட்டம் 
 ீதுமளப்   பத்திரிமய   ர ெச்மசய்    ெொேொய்ந்ரதொர் 
தூதுமளப்   பத்திரிமயத்   துய்த்து”. 
Action: 
➢ Stimulant 
➢ Expectorant 
➢ Tonic 
Chemical properties: 
The leaf and stem contain sobatum, B-solamarine, solasodine, solaine glycoalkaloid 
and diosogenin. 
OONAAN 
Botanical name : Convolvulus racemosus 
            English name  : Bindweed / Morning glory 
            Family  : Convolvulaceae 
Organoleptic character 
           Taste   : bitter, astringent 
           Potency  :   Hot 
           Division  : Acrid 
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ENNAI 
  Botanical name : Sesamum indicum 
            English name  : Sesame oil 
            Family  : Pedaliaceae 
Organoleptic character 
           Taste   : Sweet 
           Potency  :   Hot 
           Division  : Sweet 
General properties: 
“புத்திமயேக்  குளிர்ச்சி   பூரிப்பு   ம ய்ப்புளகச் 
சத்துெங்  கந்ததேி  யிளம   – ம த்தவுண்டொங் 
கண்ரணொய்   மசெிரநொய்   கபொலழல்   கொசரநொய் 
புண்ரணொய்ரபொ   ம ண்மணய்யொற்    ரபொற்று”. 
Action: 
➢ Demulcent 
➢ Laxative 
➢ Nutrient 
➢ Emollient  
Chemical constituents: 
  Seeds contain fixed oil 50 to 60 o.c., (white variety 48p.c., black and red varieties 
about 46p.c). seeds also contain proteids 22p.c. carbohydrates 18p.c. mucilage 4p.c 
woody fibre 4p.c., and ash 4.8 p.c. oil contains 70p.c of liquid fats consisting of the 
glycerides of oleic and linoleic acids and 12 to 14 p.c. of solid fats, stearin, palmitin and 
myristin; a crystalline substance sesamin and a phenol compound sesamol. 
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MATERIALS AND METHODS 
1.A. STANDARD OPERATING PROCEDURE FOR ELATHY CHOORANAM: 
SOURCE OF RAW DRUGS: 
The required raw drugs for the trial medicine were purchased from a well 
reputed country raw drug shop and drugs were authenticated by the competent authority 
Medicinal Botany and Gunapadam dept. After that the raw drugs were purified as per 
Siddha literatures then the trial drugs prepared in Gunapadam laboratory of National 
Institute of Siddha. 
 INGREDIENTS OF ELATHY CHOORANAM:  
Lavangam (Syzygium aromaticum)  - 1 part 
Milagu (Piper nigrum)   - 2 part 
Chiru nagapoo (Mesua nagassarium)  - 4 part 
Thalisapatri (Abies spectabilis)  - 8 part 
Kugai neer (Maranta arundinacea)  - 16 part 
Chukku (Zingiber officinale)   - 32 part 
Elam (Elettaria cardamomum)  - 64 part 
Sugar (Saccharum officinarum)  - 128 part 
METHOD OF PURIFICATION OF RAW DRUGS: 
Purification of Lavangam: 
 Remove the contaminated debris and dried in sunlight. 
  [Ref: Sikicha Rathina Deepam Ennum Vaithiya Nool page 29]                        
Purification of Milagu:  
Soak in butter milk for a period of one saamam (3 hours) then allow it to dry.  
             [Ref: Sikicha Rathina Deepam Ennum Vaithiya Nool page 28]                        
Purification of Chiru nagapoo:  
 Remove the contaminated debris and dried in sunlight. 
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  [Ref: Sikicha Rathina Deepam Ennum Vaithiya Nool page 29] 
Purification of Thalisapatri:  
Remove the contaminated debris and dried in sunlight. 
  [Ref: Sikicha Rathina Deepam Ennum Vaithiya Nool page 29] 
Purification of Kugai neer:  
 Mix with water and filtered for seven times. Then dried in sunlight.  
 [Ref: Sikicha Rathina Deepam Ennum Vaithiya Nool page 31] 
Purification of Chukku: 
 Dip one part of chukku in twice the part of limestone water for one samam (3 
hours). Then dried and remove the outer layer of it. 
             [Ref: Sighitcha Rathan Deepam Ennum Vaithiya Nool, Page: 29] 
Purification of Elam: 
           Remove the contaminated debris and dried in sunlight. 
  [Ref: Sikicha Rathina Deepam Ennum Vaithiya Nool page 29] 
Purification of sugar: 
 Grind the solid sugar and remove the debris using muram. 
 [Ref: Sikicha Rathina Deepam Ennum Vaithiya Nool page 34] 
METHOD OF PREPARATION: 
 Purified raw drugs were dried, pulverized in ural and filtered with cotton cloth. 
The powdered raw drugs were mixed with the sugar and stored in a container. 
1.B. STANDARD OPERATING PROCEDURE FOR PATHIRASARA VIRANA 
POOCHU THAILAM: 
Ingredients:  
Gingelly oil                                                      - 1/2  padi(0.7  lit) 
Aavarai leaf juice (Cassia auriculata)                         - 1 uri (0.7 lit) 
Vembu leaf juice  (Azadirachta indica )                     - 1 uri (0.7 lit) 
  62 
 Oonaan leaf juice  (Convolvulus racemosus)            - 1 uri (0.7 lit) 
Naayurivi leaf juice  (Achyranthes aspera)                - 1 uri (0.7 lit) 
Vetpalai leaf juice  (Wrightia tinctoria)                 - 1 uri (0.7 lit) 
Paruthi leaf juice (Gossypium herbaceum)   - 1 uri (0.7 lit) 
Puli leaf juice (Tamarindus indica)                    - 1 uri (0.7 lit) 
Thuthuvalai  leaf juice (Solanum trilobatum)  - 1 uri (0.7 lit)   
METHOD OF PREPARATION:  
All the leaf juices are mixed together with oil and then boiled till it attained the 
consistency. 
EXTERNAL WASH: 
 Arasampattai bark (Ficus religiosa) decoction is prepared and used for external 
wash on next day of oil application. 
DRUG STORAGE:  
             The trial drug Elathy chooranam was stored in clean and dry glass bottles and 
Pathirasara virana poochu thailam was stored in clean and dry narrow mouthed 
bottles. 
DISPENSING: 
The Powder was given in packet. Oil was given in pet bottles.   
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INTERNAL MEDICINE - INGREDIENTS 
 
Elam (Elettaria cardamomum)   Chukku (Zingiber officinale) 
 
  
  
Milagu ( Piper nigrum)   Kirambu (Syzygium aromaticum) 
 
Koogaineeru (Maranta arunsinacea) Sirunagapoo (Mesua nagassarium) 
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Thalisapathri (Taxus buccata)  Chakkarai (Saccharum officinarum) 
   
 
ELATHY CHOORANAM  
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EXTERNAL MEDICINES – INGREDIENTS 
 
 
Aavarai (Cassia auriculata)    Vembu (Azadirachta indica) 
 
   
 
 
 
 
Paruthi (Gossypium herbaceum)  Oonaan (Convolvulus racemosus) 
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Puli (Tamarindus indica)   Naayuruvi (Achyranthes aspera) 
 
             
 
 
 
 
Thuthuvalai (Solanum trilobatum)   Vetpalai (Wrightia tinctoria) 
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GINGELLY OIL       PATHIRASARA VIRANA POOCHU THAILAM 
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2.BIO-CHEMICAL EVALUATION 
Experimental procedure: 
5 g Elathy chooranam was taken in a 250 ml of clean 
beaker and 50ml of distilled water was added to it. Then it was 
boiled well for about 10 min. Then it is allowed to cool and 
filtered in a 100 ml volumetric flask and made up to 100 ml 
with distilled water. This preparation is used for the qualitative 
analysis of acidic/ basic radicals and biochemical constituents 
in it. 
Preparation of extract: 
5gm of Elathy chooranam is weighed accurately and placed 
in a 250ml clean beaker and 50ml of distilled water was added 
with it. Then it was boiled well for about 10 minutes. Then it 
was allowed to cool and filtered in a 100ml volumetric flask 
and made up to 100ml with distilled water. The bio-chemical 
analysis of Elathy chooranam was done at Biochemistry lab, 
National Institute of Siddha, Chennai-47. 
Preliminary test for Copper, Sodium, Silicate and Carbonate: 
➢ Test for Silicate: 
a. A little (500mg) of the sample is shaken well with distilled water. 
b. A little (500mg) of the sample is shaken well with con. HCl/Con. 
H2So4. 
➢ Action of Heat: A small amount (500mg) of the 
sample is taken in a dry test tube and heated gently at 
first and then strong. 
➢ Action of Heat: A small amount (500mg) of the 
sample is taken in a dry test tube and heated gently 
at first and then strong. 
➢ Flame Test: A small amount (500mg) of the sample 
is made into a paste with con. HCl in a watch glass and 
introduced into non-luminous part of the Bunsen 
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flame. 
➢ Ash Test: A filter paper is soaked into a mixture 
of sample and dil. cobalt nitrate solution and 
introduced into the Bunsen flame and ignited. 
Test for Acid Radicals 
➢ Test for Sulphate: 2ml of the above prepared extract 
was taken in a test tube and 2ml of 4% dil. ammonium 
oxalate solution was added. 
➢ Test for Chloride: 2ml of the above prepared extracts 
was added with 2ml of dil-HNO3 until the 
effervescence ceases off. Then 2 ml of silver nitrate 
solution was added. 
➢ Test for Phosphate: 2ml of the extract was treated with 
2ml of con. HNO3 and 2ml of dil. ammonium 
molybdate solution. 
➢ Test for Carbonate: 2ml of the extract was treated 
with 2ml dil. magnesium sulphate solution 
➢ Test for Nitrate:1gm of the substance was heated 
with copper turning and concentrated H2SO4 and 
viewed the test tube vertically down. 
➢ Test for Sulphide: 1gm of the substance was treated with 2ml of 
con. HCL 
➢ Test for Fluoride & Oxalate: 2ml of extract was 
added with 2ml of dil. Acetic acid and 2ml dil. calcium 
chloride solution and heated. 
➢ Test for Nitrite: 3drops of the extract was placed on 
a filter paper, on that-2 drops of dil. acetic acid and 2 
drops of dil. Benzidine solution were placed. 
Test for Basic Radicals 
➢ Test for Lead: 2ml of the extract was added with 2ml 
of dil. potassium iodine solution. 
➢ Test for Copper: One pinch (50mg) of substance was 
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made into paste with con. HCl in a watch glass and 
introduced into the non-luminous part of the flame. 
➢ Test for Aluminium: In the 2ml of extract dil. sodium 
hydroxide was added in 5 drops to excess. 
➢ Test for Iron: 
a) To the 2ml of extract add 2ml of dil. ammonium solution 
b) To the 2ml of extract 2ml thiocyanate solution 
and 2ml of con HNo3 is added 
➢ Test for Zinc: In 2ml of the extract dil. sodium 
hydroxide solution was added in 5 drops to excess and 
dil. ammonium chloride was added. 
➢ Test for Calcium: 2ml of the extract was added with 
2ml of 4% dil. ammonium oxalate solution 
➢ Test for Magnesium: In 2ml of extract dil. sodium 
hydroxide solution was added in drops toexcess. 
➢ Test for Ammonium: In 2ml of extract 1 ml of 
Nessler's reagent and excess of dil. sodium hydroxide 
solution were added. 
➢ Test for Potassium: A pinch (25mg) of substance was 
treated with 2ml of dil. sodium nitrite solution and then 
treated with 2ml of dil. cobalt nitrate in 30% dil. 
glacial acetic acid. 
➢ Test for Sodium: 2 pinches (50mg) of the substance 
was made into paste by using HCl and introduced into 
the blue flame of Bunsen burner. 
➢ Test for Mercury: 2ml of the extract was treated with 
2ml of dil. sodium hydroxide solution. 
➢ Test for Arsenic: 2ml of the extract was treated with 
2ml of dil. sodium hydroxide solution. 
 Other constituents 
➢ Test for Starch : 2ml of extract was treated with weak dil. iodine solution 
➢ Test for Reducing Sugar: 5ml of Benedict's qualitative solution was taken in a 
test tube and allowed to boil for 2 minutes and added 8 to 10 drops of the extract 
and again boil it for 2 minutes. 
➢ Test for the Alkaloids: 
a) 2ml of the extract is treated with 2ml of dil. potassium iodide solution. 
b) 2ml of the extract is treated with 2ml of dil. picric acid. 
➢ Test for Tannic Acid: 2ml of extract was treated with 2ml of dil. ferric chloride 
solution 
➢ Test for Unsaturated Compound: In the 2ml of extract 2ml of dil. Potassium 
permanganate solution was added. 
➢ Test for Amino Acid: 2 drops of the extract was placed on a filter paper and 
dried well, and then 20ml of Burette reagent was added in it. 
 CLINICAL STUDY       
STUDY DESIGN:  
STUDY TYPE               : An open clinical trial 
STUDY PLACE            : OPD and IPD of Ayothidoss Pandithar Hospital,  
      National Institute of Siddha, 
      Tambaram Sanatorium, Chennai - 47. 
STUDY PERIOD          : 18 Months 
SAMPLE SIZE              : 40 patients (20 IPD & 20 OPD patients included for    trial) 
 
SUBJECT SELECTION: 
         Patients reporting with symptoms of inclusion criteria were subjected to screening test and documentation. 
INCLUSION CRITERIA  
• Age : 20-60 years 
• Sex : Both male and female  
• Presence of ulcers with varicose veins 
• With or without Pain, Itching, Edema, Fibrinous exudates in the lesions 
• Hyper pigmentation 
 • Eczema around the ulcer   
• Inflammation & Induration                                                                                                         
• Willing to give specimen of blood for the investigation.  
• Permit to take photograph. 
• Willing to participate in trial and signing consent by fulfilling the condition of   Proforma. 
EXCLUSION CRITERIA 
• Diabetes Mellitus. 
• Hansen’s disease. 
• Diabetic ulcer 
• Gangrene 
• Tuberculous ulcer  
• Any other systemic illness. 
WITHDRAWAL CRITERIA 
• Intolerance to the drug and development of any serious adverse effect during drug trial. 
• Poor patient compliance & defaulters 
• Patient unwilling to continue the course of clinical Study. 
• Occurrence of any other systemic illness 
TESTS AND ASSESMENTS: 
            1. Clinical assessment  
2. Siddha system assessment 
3. Routine investigations 
1. CLINICAL ASSESMENT: 
• Presence of ulcers with varicose veins 
• With or without Pain, Itching, Edema, Fibrinous exudates in the lesions 
• Hyper pigmentation 
• Eczema around the ulcer  
• Inflammation & Induration                                                                                                          
  
Improvement assessed by following assessment: 
1.    The Outcome of the treatment were observed by Venous clinical severity score (VCSS) before and after 
treatment. 
 
VENOUS CLINICAL SEVERITY SCORE      
  ATTRIBUTE ABSENT=0        MILD=1        MODERATE=2          SEVERE=3 
 
 
PAIN 
 
NONE 
 
OCCASIONAL, 
NOT 
RESTRICTING 
ACTIVITY OR 
REQUIRING 
PAIN 
MEDICATION 
 
DAILY 
MODERATE 
ACTIVITY 
LIMITATION; 
OCCASIONAL 
PAIN 
MEDICATION 
 
DAILY, SEVERE 
LIMITING 
ACTIVITIES OR 
REQUIRING 
REGULAR USE OF 
PAIN 
MEDICATIONS 
 
VARICOSE 
VEINS 
 
NONE 
 
FEW 
SCATTERED 
 
MULTIPLE; 
GREAT  
SAPHENOUS 
VEINS, 
CONFINED TO 
CALF 
AND THIGH 
 
EXTENSIVE; THIGH 
AND CALF OR 
GREAT AND SMALL 
SAPHENOUS 
DISTRIBUTION 
 
VENOUS 
EDEMA 
 
NONE 
 
EVENING 
ANKLE 
SWELLING 
ONLY 
 
AFTERNOON 
SWELLING, 
ABOVE ANKLE 
 
MORNING 
SWELLING ABOVE 
ANKLE AND 
REQUIRING 
ACTIVITY CHANGE, 
ELEVATION 
 
SKIN 
PIGMENTATION 
 
NONE 
 
DIFFUSE, BUT 
LIMITED IN 
AREA AND OLD 
(BROWN) 
 
DIFFUSE OVER 
MOST OF 
GAITER 
DISTRIBUTION 
(LOWER 
THIRD) OR 
RECENT 
PIGMENTATION 
(PURPLE) 
 
WIDER 
DISTRIBUTION 
(ABOVE 
LOWER THIRD) PLUS 
RECENT 
PIGMENTATION 
 
INFLAMMATIO
N 
 
NONE 
 
MILD 
CELLULITIS, 
LIMITED 
TO MARGINAL 
AREA 
AROUND 
ULCER 
 
MODERATE 
CELLULITIS, 
INVOLVES MOST 
OF (LOWER 
THIRD) 
 
SEVERE CELLULITIS 
(LOWER 
THIRD AND ABOVE) 
OR SIGNIFICANT 
 
INDURATION 
 
NONE 
 
FOCAL, 
CIRCUMMALL
EOLAR 
 
MEDIAL OR 
LATERAL, LESS 
THAN LOWER 
THIRD OF LEG 
 
ENTIRE LOWER 
THIRD OF LEG OR 
MORE 
  
NUMBER OF 
ACTIVE 
ULCERS 
 
0 
 
1 
 
2 
 
>2 
 
ACTIVE ULCER 
DURATION 
 
NONE 
 
<3 MONTHS 
 
>3 MONTHS, 
<1YEAR 
 
NOT HEALED>1 
YEAR 
 
ACTIVE ULCER 
DIAMETER 
 
NONE 
 
<2 
 
2-6 
 
>6 
 
COMPRESSION 
THERAPY 
 
NOT USED 
OR 
PATIENT 
NOT 
COMPLIAN
T 
 
INTERMITTAN
T USE OF 
STOCKINGS 
 
WEARS ELASTIC 
STOCKING 
MOST DAYS 
 
FULL COMPLIANCE, 
STOCKINGS+ELEVA
TION 
 
1. INVESTIGATIONS BASED ON SIDDHA SYSTEM: 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
       8.Moothiram 
               ● Neerkkuri:   ● Neikkuri   : 
1. INVESTIGATION: 
BLOOD 
▪ Hb 
▪ Total WBC Count 
▪ DC 
• Polymorphs 
• Lymphocytes  
• Eosinophils 
• Monocytes  
• Basophils  
  
▪ Total RBC count  
▪ ESR 
        ½ Hr:                   1 Hr: 
▪ Blood sugar 
Fasting:    PP: 
▪ Serum cholesterol 
URINE 
▪ Albumin 
▪ Sugar(F)                          (PP) 
▪ Deposits 
RENAL FUNCTION TESTS 
             Blood Urea 
             Serum Creatinine 
             Uric acid 
LIVER FUNCTION TESTS 
              Serum total bilirubin 
              Direct bilirubin 
              Indirect bilirubin 
              Serum Alkaline phosphatases 
              SGOT 
             SGPT 
DATA COLLECTION: 
Required information were collected from each patient by using the following forms 
FORMS:  
FORM I            Screening and selection Proforma 
FORM II           Clinical assessment Proforma 
FORM III          Laboratory investigation Proforma 
FORM IV         Drug compliance form  
FORM V          Patient information sheet 
FORM VI         Consent form 
FORM VII       Withdrawal form/Pharmacovigilance 
FORM VIII      Dietary Advice form 
STUDY ENROLLMENT: 
 ➢ Patients reporting at the OPD with clinical features of chronic ulcer, oedema, skin hyperpigmentation, 
fibrinous exudate, itching and eczema around the ulcer are chosen for enrolment based on the inclusion 
and exclusion criteria. 
➢ The enrolled patients were informed about the study, trial drug, possible outcomes and the objectives of 
the study in the language and terms understandable to them and getting consent in the Informed Consent 
form (Form VI). 
➢ Complete clinical history, complaints and duration, examination findings-- all would be recorded in the 
prescribed Performa’s. 
Screening Form- I was filled up, Form –II and Form –III were used for recording the patients, history, clinical 
examination of symptoms and signs and laboratory investigations respectively. If there is any abnormal laboratory 
reports obtained then excluded from this study. Patients would be advised to take the trial drug and appropriate 
dietary advice (Form VIII)   would be given according to the patients, perfect understanding.  
CONDUCT OF THE STUDY: 
The day before the treatment Purgation was given with Agasthiyar Kuzhambu -200mg in the early 
morning in empty stomach with Sangankuppi chaaru for balancing the deranged mukkutram. Then the trial drugs 
“ELATHY CHOORANAM” (Internal) and “PATHIRASARA VIRANA POOCHU THAILAM” (External) were 
given for 45 days.   
  OPD patients were requested to visit the hospital once in 7 days. In each and every visit clinical assessment 
and prognosis were recorded in the presence of faculty members. For IPD patients the clinical assessment and 
prognosis were recorded daily.  
            Laboratory investigations were done before and after the trial. For IPD patients, who were not in a position 
to stay in the hospital for a long time were advised to attend the OPD for further follow-up. At the end of the trial, 
the patients were advised to visit the OPD for further 2 months for follow-up for any recurrence. Defaulters were 
allowed to continue and were withdrawn from the study with fresh case being inducted. 
 
  
ADVERSE/SERIOUS EFFECTS MANAGEMENT: 
PATIENT SCREENING 
Inclusion/Exclusion 
INCLUSION CRITERIA EXCLUSION CRITERIA 
EXCLUDED FROM TRIAL 
METHODOLOGY 
STUDY NUMBER 
HISTORY TAKING 
LAB INVESTIGATION 
 TRIAL DRUG  
CLINICAL ASSESSMENT 
OUTCOME 
INFORM ABOUT STUDY AND 
TRIAL DRUG 
INFORMED CONSENT FORM 
ADVERSE REACTION 
ADVICED TO TAKE 
TREATMENT IN OPD 
ABNORMAL VALUES 
VALUES 
PHARMACOVIGILANCE 
DEPARTMENT 
FURTHER MANAGEMENT OF 
ADVERSE DRUG REACTION 
 If the trial patient develops any adverse reaction, he/she would be immediately withdrawn from the trial 
and were directed to take treatment in OPD of NIS. It was also be reported to the Pharmaco-vigilance committee 
of NIS.  
DATA ANALYSIS: 
                 After enrolling the patients in the study, a separate file for each patient was  maintained and all forms 
were kept in the file. Study No. and patient’s No. were entered on the top of the file for easy identification. 
Whenever the patients visit OPD during the study period, necessary entries were made at the assessment forms.  
The screening forms were filled separately. 
            All forms were further scrutinized by Senior Research Officer (Statistics) for logical errors and 
incompleteness of data to avoid any bias. No modification in the results is permitted for unbiased reports. 
ETHICAL ISSUES: 
 The patients were informed about the treatment and other procedures in his vernacular language. After 
getting the consent only (language understandable to the patient) they were enrolled in the study.  
 To prevent any infection, while collecting blood sample from the patient, only disposable syringes, 
disposable gloves, with proper sterilization of lab equipment's were used.                         
 The data collected from the patient was kept confidential.  
 Treatment was provided free of cost.  
 If any adverse reactions occur it was reported to the Pharmacovigilance committee of NIS and they were 
advised to take treatment at the OPD of National Institute of Siddha. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
OBSERVATION AND 
RESULTS
  
RESULTS OF BIO-CHEMICAL ANALYSIS 
Qualitative Analysis 
 
SL. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample 
Whitish in Colour  
2. Solubility: 
a. A little of the sample is 
shaken well with distilled 
water. 
b. A little of the sample is 
Shaken well with con. Hcl 
Con. H2SO4. 
 
Completely 
soluble 
 
 
 
 
Completely soluble 
 
 
 
 
 
 
 
Absence of 
Silicate 
3. Action of Heat: 
A small amount of the sample is 
taken in a dry test tube and 
heated gently at first and then 
Strong. 
 
No White 
fumes 
evolved 
Brown fumes not 
Evolved 
 
Absence of 
Carbonate. 
Absence of 
Nitrate. 
4. Flame Test: 
A small amount of the sample is 
made into a paste with con. Hcl 
in a watch glass and introduced 
into non-luminous 
part of the Bunsen flame. 
 
White flame is 
appeared 
 
Absence of 
Copper. 
5 Ash Test: 
A filter paper is soaked into a 
mixture of sample and cobalt 
nitrate solution and introduced 
into the Bunsen flame and 
ignited. 
 
No Yellow colour 
flame. 
 
Absence of 
Sodium. 
 Preparation of the Extract 
5 gm of Elathy chooranam was weighed accurately 
and placed in a 250 ml clean beaker. Then 50 ml distilled 
water was added and dissolved well. Then it is boiled well for 
about 10 minutes. It was cooled and filtered in a 100 ml 
volumetric flask and then it was made up to 100 ml with 
distilled water. This fluid was taken for analysis. 
 
SL. 
NO. 
EXPERIMENT OBSERVATION INFERENCE 
I.TEST FOR ACID RADICALS 
1. Test For Sulphate: 
a. 2 ml of the above prepared 
extract is taken in a test tube to 
this added 2ml of 4% ammonium 
oxalate solution. 
b. 2ml of the above prepared 
extract is added with 2 ml of dil- 
Hcl is added until the 
effervescence ceases off. Then 
2ml of Barium chloride solution 
is added. 
 
 
No Cloudy 
appearance present 
 
 
 
 
No white precipitate 
insoluble in con. 
Hcl is obtained 
 
 
Absence of 
Sulphate 
 
 
 
 
Sulphate is 
Not 
Confirmed. 
2. Test For Chloride: 
2 ml of the above prepared 
Extract is added with dil. HNO3 
till the effervescence ceases. 
Then 2 ml of silver nitrate 
solution is added. 
 
 
No Cloudy 
appearance present 
(Mild trace 
element) 
 
 
 
Absence of 
Chloride 
 3. Test For Phosphate: 
2 ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2 ml of con. HNO3 
 
No Cloudy yellow 
appearance Present 
 
Absence of 
Phosphate 
4. Test For Carbonate: 
2m1 of the extract is treated with 
2m1 magnesium sulphate 
Solution 
 
 
No cloudy 
appearance 
 
Absence of 
Carbonate 
5 Test For Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated H2SO4 and viewed 
the test tube vertically down. 
 
Brown gas is not 
evolved 
 
Absence of 
Nitrate 
6. Test For Sulphide: 
1 gm of the substance is 
treated with 2m1 of con. Hcl. 
 
No Rotten egg 
Smelling gas 
Evolved 
 
Absence of 
Sulphide. 
7. Test for fluoride & oxalate 
2 m1 of The Extract Is Added 
With 2m1of Acetic Acid and 2 
m1 calcium Chloride solution 
and heated. 
 
 
No Cloudy 
appearance. 
 
 
Absence of 
Fluoride & 
Oxalate 
8. Test for Nitrite: 
3drops of extract is placed on a 
filter paper,on that 2 drops of 
acetic Acid and 2 drops of 
benzidine solution is placed. 
 
 
No characteristic 
Changes. 
 
 
Absence of 
nitrite. 
 9. Test For Borate: 
2 pinches of the substance is made 
into paste by using sulphuric acid 
and alcohol (95%) and introduced 
into the blue 
flame. 
 
 
Bluish green colour 
flame not appeared 
 
 
Absence of 
borate. 
 
 
 
 
 
II. TEST FOR BASIC RADICALS 
1 Test For Lead: 
2 m1of the extract is added with 
2m1of potassium iodide solution. 
 
No Yellow 
precipitate 
is obtained 
 
Absence of Lead. 
2. Test for Copper: 
a. One pinch of substance is 
made into paste with con. Hcl in 
a watch glass and introduced 
into the non-luminous part of the 
flame. 
b. 2 ml of extract is added with 
excess of ammonia solution. 
 
No Blue colour 
flame 
precipitate 
 
 
 
 
No Blue colour 
precipitate 
 
Absence of 
Copper. 
 
 
 
 
 
Absence of 
Copper. 
3. Test For Aluminium: 
Take the 2m1of the extract 
sodium hydroxide is added in 
drops to excess. 
 
No characteristic 
changes 
 
Absence of 
Aluminium. 
 4. Test For Iron: (Ferrous) 
To the 2 ml of extract 2m1 
ammonium thiocyanate solution 
and 2m1of con.HNO3 is added. 
 
No Blood red 
colour Appeared 
 
 
Absence of Iron 
5. Test For Zinc: 
To 2m1 of the extract sodium 
hydroxide solution is added in 
drops to excess. 
 
White precipitate is 
not 
Formed 
 
Absence of Zinc. 
6. Test For Calcium: 
2m1 of the extract is added with 
2m1 of 4% ammonium oxalate 
Solution. 
No Cloudy 
appearance and 
white precipitate 
is obtained 
 
Absence of 
Calcium. 
7. Test For Magnesium: 
To 2ml of extract sodium 
hydroxide solution is added in 
drops to excess. 
 
White precipitate 
is not 
obtained. 
 
Absence of 
Magnesium. 
8. Test For Ammonium: 
To 2ml of extract few ml of 
Nessler's reagent and excess of 
sodium hydroxide solution are 
added. 
 
 
No brown colour 
appeared. 
 
 
Absence of 
Ammonium. 
9. Test For Potassium: 
A pinch of substance is treated 
with 2ml of sodium nitrite 
solutionand then treated with 
2m1 of cobalt nitrate in 30% 
glacial acetic acid. 
 
No Yellowish 
precipitate is 
obtained 
 
Absence of 
Potassium. 
10. Test For Sodium: 
2 pinches of the substance is made 
into paste by using HCL and 
introduced into the blue 
flame of Bunsen burner. 
 
 
No Yellow colour 
Flame appeared. 
 
 
Absence of 
Sodium. 
 11. Test For Mercury: 
2m1 of the extract is treated with 
2ml of sodium hydroxide 
solution. 
 
Yellow precipitate 
is not obtained 
 
Absence of 
Mercury. 
12. Test For Arsenic: 
2m1 of the extract is treated with 
2m1 of sodium hydroxide 
solution. 
 
 
No brownish red 
Precipitate is 
obtained 
 
 
Absence of 
Arsenic. 
  
III. MISCELLANEOUS 
1. Test for Starch: 
2ml of extract is treated with weak 
iodine solution. 
 
Blue colour 
developed 
 
Presence of 
Starch 
2. Test For Reducing Sugar: 
5. ml of Benedict's qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for 2 minutes. 
The colour changes are noted. 
 
 
Brick red colour 
developed 
 
 
Presence of 
Reducing sugar. 
3. Test For The Alkaloids: 
a. 2m1 of the extract is treated 
with 2ml of potassium Iodide 
solution. 
 
Red colour 
developed 
 
Presence of 
Alkaloid. 
  
b. 2m1 of extract is treated with 
2ml of picric acid. 
 
 
Trace Yellow 
colour developed 
 
Trace of 
Alkaloid present. 
 c. 2m1 of the extract is treated with 
2ml of phosphotungstic acid. 
 
White precipitate 
developed 
Presence of 
Alkaloid. 
 4. Test for Tannic Acid: 
2ml of extract is treated with 
2ml of ferric chloride solution. 
 
No Black 
precipitate is 
obtained 
 
Absence of 
Tannic acid. 
5. Test for Unsaturated 
Compound: 
To the 2ml of extract 2ml of 
Potassium Permanganate solution 
is added. 
 
Potassium 
Permanganate is 
not decolourised 
 
Absence of 
Unsaturated 
Compound 
6. Test For Amino Acid: 
2 drops of the extract is placed on 
a filter paper and dried well and 2 
ml of biuret reagent is added 
 
No Violet colour 
developed 
 
Absence of 
Amino acids. 
 7. Test For type of Compound: 
2ml of the extract is treated with 
2 ml of ferric chloride solution. 
 
No Green 
colour 
developed 
 
 
 
 
 
No Red colour 
developed 
 
 
 
 
 
No Violet colour 
developed 
 
 
 
 
No blue 
colour 
Developed 
 
Absence of oxy 
quinole 
epinephrine 
and pyro 
catechol. 
 
Anti pyrine, 
Aliphatic 
amino acids and 
Meconic acid 
are absent. 
 
Apomorphin
e, Salicylate 
and 
Resorcinol 
are absent. 
 
Morphine, 
Phenol 
cresol and 
hydro quinone 
are 
absent 
 
RESULT: 
The Bio-chemical analysis of Elathy chooranam had shown the 
presence of  Starch, Reducing  Sugar and Alkaloids. 
 
 
 
 
 CLINICAL STUDY 
The observation and results were studied and tabulated under the following 
heading. 
1) Age distribution 
 
2) Sex distribution 
 
3) Occupational History 
 
4) Family History 
 
5) Diet habits 
 
6) Thinai reference 
 
7) Paruvakaalam 
 
8) Kaalam distribution (According to age) 
 
9) Yakkai Ilakkanam (Physical Constitution) 
 
10) Gunam reference 
 
11) Duration of illness 
 
12) Clinical features 
 
13) Distributions of three thodams 
 
14) Udar Kattukkal reference 
 
15) En Vagaithervugal 
 
16) Neerkkuri reference 
 
17) Neikkuri reference 
 
18) Results 
 
 
 1) Age Distribution  
 
S. No. Age No of Cases Percentage 
1. 20-30 0 0% 
2. 31-40 10 25% 
3. 41-50 13  32.5% 
4. 51-60 17 42.5% 
 
 
 
 
 
 
Observation: 
 
 The patients were selected from all age groups as given above and the maximum 
of  patients (17) were in the age between 51 and 60 years. 
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Age Distribution
 2) Sex Distribution  
 
S. No. Sex No of Cases Percentage 
1. Male 38 95% 
2. Female 2 5% 
 
 
 
Observation: 
 Among 40 patients, 95% were males and 5% were females.  
 
 
 
 
 
 
 
 
 
95%
5%
Sex Distribution
Male
Female
 3) Occupational Status 
S. No. Nature of Work No. of Cases Percentage 
1. EB Employee 
 
1 2.5% 
2. Shop Keeper 9 22.5% 
3. Tailor 2 5% 
4. Barber 2 5% 
5. Attender 6 15% 
6. Farmer 10 25% 
7. Watchman 5 12.5% 
8. Home maker 2 5% 
9. Businessman 2 5% 
10. Painter 1 2.5% 
 
 
Observation: 
 The majority of patients in this study were farmers and shop keepers. 
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5%
5%
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Occupational status
 4) Family History 
S. No. Criteria No of Cases Percentage 
1. Family History - 
Yes 
6 15% 
2. Family History - 
No 
34 85% 
 
 
 
Observation: 
 85% of patients showed negative family history. 15% positive family history 
emphasized the genetic cause. 
 
 
 
 
 
 
 
15%
85%
Family History
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 5) Dietary Habits 
Sl. No Dietary Habits No of Cases Percentage 
1. Vegetarian 2 5% 
2. Non Vegetarian 38 95% 
 
 
Observation: 
 95% of the patients were non-vegetarians. 
 
 
 
 
 
 
 
 
 
5%
95%
Diatary Habits
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 6) Thinai Reference 
Sl.No Thinai No of Cases Percentage 
1. Kurinji (Hill Area) 0 0% 
2. Mullai (Forest 
Area) 
0 0% 
3. Marutham 
(Fertile Land) 
7 17.5% 
4. Neithal (Costal 
Area) 
33 82.5% 
5.  Paalai (Desert 
Land) 
0 0% 
 
 
Observation: 
 82.5% of thepatients were from Neithal ( coastal area ) and 17.5% of patients were 
from Marutham (Fertile land). 
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 7) Paruvakaalam: 
Sl. No. Kaalam 
Distribution 
No of Cases Percentage 
1. Kaar Kaalam 0 0% 
2. Koothir Kaalam 4 10% 
3. Munpani Kaalam 7 17.5% 
4. Pinpani Kaalam 18 45% 
5. Ilavenil Kaalam 11 27.5% 
6. Muthuvenil 0 0% 
 
 
Observation: 
 45% patients admitted in pinpani kaalam, 27.5% patients admitted in Ilavenil 
kaalam, 17.5% patients admitted in munpani kaalam and remaining 10% patients 
admitted in koothir kaalam. 
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 8) Kaalam Distribution (According to Age) 
In Siddha literature human life has been divided into three periods as follows  
1) Vaatham  
2) Pitham  
3) Kabam  
 
The duration of each period is said to be 33 years 
Sl. No. Kaalam No of Cases Percentage 
1. Vaatha Kaalm (1-
33) 
3 7.5% 
2. Pitha Kaalam (34-
66) 
37 92.5% 
3. Kaba Kaalam (67-
100) 
0 0% 
 
 
Observation: 
92.5% of the patients in pitha kaalam and the remaining 7.5% patients reported in vatha 
kaalam. 
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 9) Yaakai Ilakkanam (Physical Constitution) 
 
Sl.No Yaakai Ilakkanam No. of Cases Percentage 
1. Vaatha Udal   0 0% 
2 Pittha Udal    0 0% 
3. Kaba Udal   0 0% 
4. Thontha Udal  40 100% 
 
Observation: 
 All the patients (100%) had thontha udal.  
 
10) Gunam (Quality and Characters) 
Sl.No Gunam No. of Cases Percentage 
1. Sathuva Gunam 0 0% 
2. Rajo Gunam 40 100% 
3. Thamo Gunam 0 0% 
 
Observation: 
 All the patients (100%) had Rajo gunam. 
 
 
 
 
 
 11) Duration of Illness 
Sl.No Duration of Illness No of Cases Percentage 
1. 0-3 Months 3 7.5% 
2. 4-6 Months 5 12.5% 
3. 7-9 Months 3 7.5% 
4. 10-12 Months 5 12.5% 
5. >1 Year 24 60% 
 
 
Observation: 
 60% of the patients were suffering with the illness for more than 1 year. 
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  12) Clinical Features 
Sl.No Clinical Features No. of  Cases Percentage 
1. Ulcer with varicose vein 40 100% 
2. Pain 39 97.5% 
3. Hyperpigmentation around the 
ulcer 
40 100% 
4. Itching 28 70% 
5. Fibrous exudates 29 72.5% 
6. Inflammation 10 25% 
7. Swelling 31 77.5% 
8. Ezcema around the Ulcer 8 20% 
9.      Induration 10   25% 
 
 
  
 
Observation: 
 All the patients in the study had clinical features of ulcer with varicose vein and 
hyperpigmentation around the ulcer. 97.5% patients were suffering from pain. 77.5% 
of patients had swelling and 70% had itching. 
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 13) Distribution of Mukkutram - Vaatham 
Sl.No. Classification of 
Vaatham 
No of Cases Percentage 
1. Praanan 0 0% 
2.  Abaanan 5 12.5% 
3. Udhaanan 0 0% 
4. Viyanan 40 100% 
5. Samaanan 40 100% 
6. Naagan 0 0% 
7. Koorman 0 0% 
8. Kirukaran 0 0% 
9. Devathatthan 0 0% 
10. Dananjayan 0 0% 
 
 
Observation: 
 Samaanan and Viyaanan were affected in all the 40 patients. 
Abaanan was affected in 12.5 % cases. 
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Classification of Vaatham
 Pitham 
Sl.No Classification of 
Pitham 
No of Cases Percentage 
1. Anar pitham 0 0% 
2. Ranjaga pitham 0 0% 
3. Saathaga pitham 40 100% 
4. Pirasaga pitham 40 100% 
5.  Aalosaga pitham 0 0% 
 
 
 
Observation: 
 Pirasaga pitham and saathaga pitham were affected in all the cases. 
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 Kabam 
Sl.No Classification of 
Kabam 
No of Cases Precentage 
1. Avalambagam 0% 0% 
2. Kilethagam 0% 0% 
3. Pothagam 0% 0% 
4. Tharpagam  0% 0% 
5. Santhigam 04 10% 
 
 
Observation: 
 In 10% of patients santhigam was affected. 
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 14) Udal Kattukkal 
Sl.No Udal Kattukkal No of Cases Percentage 
1. Saaram 40 100% 
2. Senneer 40 100% 
3. Oon  40 100% 
4. Kozhuppu 0 0% 
5. Enbu 0 0% 
6. Moolai 0 0% 
7. Sukkilam/Suronitham 0 0% 
 
 
Observation: 
 Saaram,senneer and oon were affected in all cases. 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
100% 100% 100%
0% 0% 0% 0%
Udal Kattukkal
 15) Envagai Thervugal 
Sl .No Envagai Thervugal No of Cases Percentage 
1. Naadi 
a. Vatha pitham 25 62.5% 
b. Pitha vatham 10 25% 
c. Pitha kabam 04 10% 
d. Kabapitham 01 2.5% 
2. Sparisam 40 100% 
3. Naa 0 0% 
4. Niram 40 100% 
5. Mozhi 0 0% 
6. Vizhi 0 0% 
7. Malam 5 17.5% 
8 Moothiram 0 0% 
Observation 
In Envagai thervugal, Niram and Sparisam were 
affected in all the 40 cases. The Naadinadai seen in 
Kaalanjagapadai patients were Vaathapitham 62.5%, 
Pithavaatham 25%, Pithakabam 10%, Kabapitham 2.5%. 
 
 
 
 
 
 Neerkuri and Neikuri 
Sl.No Type of Test No of Cases Percentage 
1. Neerkkuri 
“Niram”-Pale 
yellow 
                -Dark 
yellow 
40 100% 
Neikkuri 
2. (Vaadham) 
“Aravna Neendal” 
24 60% 
(Pitham) “Azhipol 
Paraviyathu 
12 30% 
(Kabam) 
“Muththothu 
ninrathu” 
04 10% 
Others 0 0% 
 
 
 
Observation: 
Among 40 cases, 60 % of patients had Vaatha neer 
neikkuri, 30% had Pitha neer neikkuri and only 10% had 
Kaba neer neikkuri 
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 VCSS Score 
 
S. No. 
 
OP/ IP NO. 
 
AGE / SEX 
VCSS  
VCSS ( 
 
RESULT 
BT AT 
1. 0003-17 54/M 12 4 66.7 Moderate 
2. 0705-18 47/M 16 11 31.25 Mild 
3. 0043-17 44/M 12 3 75 Good 
4. 0152-17 60/M 18 13 27.78 Mild 
5. 0188-17 39/F 14 7 50 Moderate 
6. 0417-18 60/F 15 12 20 Poor 
7. J 76642 60/M 13 3 76.92 Good 
8. J 71909 31/M 9 3 66.66 Moderate 
9. 10040 49/M 8 2 75 Good 
10. J 69785 37/M 8 2 75 Good 
11. J 44174 60/M 15 10 33.33 Mild 
12. J 82520 51/M 15 12 20 Poor 
13. 0052-17 45/M 15 8 46.66 Mild 
14. 8784-17 50/M 13 2 84.61 Good 
15. J 94994 41/M 11 9 18.18 Poor 
16. J 99259 48/M 14 11 21.42 Poor 
17. K 05153 40/M 12 8 33.33 Mild 
18. J 76696 55/M 11 7 36.36 Mild 
19. J 44175 50/M 14 8 42.85 Mild 
20. J 99230 38/M 10 2 80 Good 
21. 0525-18 42/M 17 10 41.17 Mild 
22. J 89710 58/M 10 2 80 Good 
23. G 42979 42/M 10 2 80 Good 
24. K 13310 40/M 9 2 77.77 Good 
 25. J 68842 57/M 12 9 25 Mild 
26. I 04968 38/M 14 9 35.71 Mild 
27.  G 67933 52/M 10 5 50 Moderate 
28. 0524-18 34/M 8 2 75 Good 
29. K 11106 60/M 12 11 8.33 Poor 
30. 0576-18 60/M 12 7 41.66 Mild 
31. I 73715 56/M 11 8 27.27 Mild 
32. G 28368 45/M 11 8 27.27 Mild 
33. J 84180 51/M 7 3 57.14 Moderate 
34. K 13154 32/M 10 2 80 Good 
35. K 22613 60/M 11 7 36.36 Mild 
36. I 12036 42/M 13 8 38.46 Mild 
37. K 09162 37/M 11 10 9.09 Poor 
38. 0639-18 57/M 21 19 9.52 Poor 
39. 0687-18 52/M 10 2 80 Good 
40. K 25942 43/M 12 2 83.33 Good 
 
Note: 
BT: Before treatment;  AT: After treatment 
 
Venous Clinical Severity Score (VCSS): 
VCSS 0-25 = 0-25% (poor) reduction in the VCSS in before and after treatment 
VCSS 25-50 = 25-50% (mild) reduction in the VCSS in before and after treatment 
VCSS 50-75 = 50-75% (moderate) reduction in the VCSS in before and after treatment 
VCSS 75-100 = 75-100% (good) reduction in the VCSS in before and after treatment 
 
 
 
 
  
18) Results 
Sl. No Results No of Cases (Among 
the 40 Patients) 
Percentage 
1. Good 13 32.5% 
2. Moderate 5 12.5% 
3. Mild 15 37.5% 
4.  Poor 7 17.5% 
 
 
Observation: 
 Good improvement was observed in 13 patients (32.5%), moderate improvement in 5 patients (12.5%), 
mild improvement in 15 patients (37.5%) and poor improvement in 7 patients (17.5%). 
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STATISTICAL ANALYSIS 
  
 
STATISTICAL ANALYSIS 
All collected data were entered into MS Excel software using different columns 
as variables and rows as patients. SPSS software was used to perform statistical analysis. 
Basic descriptive statistics include frequency distributions and cross- tabulations were 
performed. The quantity variables were expressed as Mean ± Standard Deviation and 
qualitative data as percentage. A probability value of <0.05 was considered to indicate as 
statistical significance. Paired t test was performed for determining the significance 
between before and after treatment. 
 
Paired Sample Statistics (VCSS Before Treatment and After Treatment) 
Variable Obs Mean±SD t Value p 
Value 
Before treatment 40 12.15±2.92 
t=13.97 p 
<0.0001 
After treatment 40  6.63±4.14 
 
The mean± standard deviation of  VCSS at before and after treatment were 12.15±2.92 and 6.63±4.14 
respectively which is considered extremely significant (t=13.97, p=0.0001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
IP No. 0003-17, 54 years / Male 
BEFORE TREATMENT  AFTER TREATMENT 
     
 
 
OP No.J76642, 60 years / Male  
BEFORE TREATMENT  AFTER TREATMENT 
   
 
 
 
 
  
 
 
 
LABORATORY 
INVESTIGATIONS
  
 
 
INVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
 
S. 
NO
. 
 
 
 
IP / OP 
NO. 
 
 
AGE / 
SEX 
 
 
Hb (gm/ 
dl) 
TOTAL 
RBC 
COUNT 
(million/ 
cu.mm) 
 
ESR (mm/ 
hour) 
TOTAL 
WBC (cells/ 
cu.mm) 
BT AT BT AT BT AT BT AT 
1. 0003-17 54/M 12.2 13.4 4.1 4.5 24/35 8/18 6300 7900 
2. 0705-18 47/M 13.7 13.4 4.6 4.4 16/32 12/24 5800 6200 
3. 0043-17 44/M 15.8 16.4 4.7 5.2 8/12 4/6 6400 6800 
4. 0152-17 60/M 13.8 13.6 4.5 4.7 13/24 8/12 9200 9600 
5. 0188-17 39/F 12 12.4 5.0 5.2 4/12 4/12 7300 7600 
6. 0417-18 60/F 11.4 11.6 5.1 5.3 4/8 2/4 7500 7700 
7. J 76642 60/M 13.3 13.6 4.8 5.0 6/10 4/8 7700 7400 
8. J 71909 31/M 12.4 12.6 4.3 4.4 26/52 22/48 7500 7600 
9. 10040 49/M 13.7 13.6 4.4 4.8 10/20 8/10 5100 5400 
10. J 69785 37/M 15.2 15.4 5.2 5.2 2/6 4/8 6300 6200 
11. J 44174 60/M 16 16.2 5.2 5.2 12/18 4/8 8000 8200 
12. J 82520 51/M 11.5 11.7 4.8 5.1 18/24 4/8 6700 7000 
13. 0052-17 45/M 14.8 15.8 4.7 5.4 4/8 2/12 7300 7500 
14. 8784-17 50/M 14.5 15.9 5.2 5.5 8/12 4/7 8200 8400 
15. J 94994 41/M 14.6 14.8 4.3 4.2 4/12 2/8 6600 6400 
16. J 99259 48/M 15 14.8 5.1 4.9 12/20 2/4 8100 7900 
17. K 05153 40/M 15.0 15.2 5.3 5.2 2/6 2/8 7800 7600 
18. J 76696 55/M 16 13.8 5.1 4.5 6/14 20/40 8300 7900 
19. J 44175 50/M 8.6 9.2 3.7 3.8 30/62 24/54 8000 7600 
20. J 99230 38/M 13.7 13.4 4.7 4.5 24/50 18/32 6900 7200 
21. 0525-18 42/M 12.6 12.4 4.8 5.0 22/44 18/38 6800 7100 
22. J 89710 58/M 15.7 15.5 5.2 5.8 2/4 4/8 7000 7200 
23. G 42979 42/M 15.7 15.4 4.7 4.5 8/18 2/6 7200 6900 
24. K 13310 40/M 13.1 13.2 5.1 4.9 13/25 12/19 6300 6200 
25. J 68842 57/M 7.4 8.2 4.7 4.6 40/80 34/78 5100 5800 
26. I 04968 38/M 14.6 15 4.7 4.6 4/8 8/12 9500 8400 
 27. G 67933 52/M 13.8 14.2 4.8 5.2 2/4 8/12 8600 9200 
28. 0524-18 34/M 13.5 13.8 4.6 4.8 10/22 8/16 4700 4900 
29. K 11106 60/M 16.6 16.2 4.5 5.2 4/6 2/8 7000 6900 
30. 0576-18 60/M 15.9 15.4 5.3 5.1 2/4 2/4 8400 7600 
31. I 73715 56/M 15 14.7 5.2 5.0 2/4 6/12 5900 6500 
32. G 28368 45/M 13.8 15.0 4.7 4.6 4/8 4/6 6200 6400 
33. J 84180 51/M 16.2 16.2 5.3 5.5 20/40 12/20 7700 7600 
34. K 13154 32/M 16 16.2 5.3 5.2 2/4 2/8 9700 9400 
35. K 22613 60/M 15.6 14.8 5.1 5.3 2/4 2/4 8500 8900 
36. I 12036 42/M 16 16.4 5.4 5.5 8/16 4/8 6200 6600 
37. K 09162 37/M 13.8 13.8 5.2 5.1 20/40 10/20 7700 7400 
38. 0639-18 57/M 11.2 11.5 4.3 4.4 13/62 52/92 7100 7900 
39. 0687-18 52/M 15.8 16 5.2 5.8 2/4 4/8 7200 7800 
40. K 25942 43/M 16.2 16.2 5.3 5.5 20/40 10/20 7700 7900 
 
INVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
S. 
No. 
 
OP / IP No. 
 
AGE / SEX 
SGOT 
(IU/L) 
SGPT (IU/L) Alkaline 
phosphatase 
BT AT BT AT BT AT 
1. 0003-17 54/M 31 31 23 23 109 99 
2. 0705-18 47/M 25 26 26 30 80 120 
3. 0043-17 44/M 37 35 33 30 85 82 
4. 0152-17 60/M 20 20 30 35 110 109 
5. 0188-17 39/F 20 20 30 30 110 90 
6. 0417-18 60/F 26 26 30 35 98 120 
7. J 76642 60/M 20 20 30 30 115 110 
8. J 71909 31/M 20 20 26 28 105 110 
9. 10040 49/M 33 35 25 26 130 130 
10. J 69785 37/M 38 38 23 23 115 115 
11. J 44174 60/M 30 30 35 35 110 110 
12. J 82520 51/M 17 21 11 15 87 92 
13. 0052-17 45/M 20 25 30 30 90 95 
14. 8784-17 50/M 28 30 35 35 110 110 
15. J 94994 41/M 30 25 36 36 95 89 
16. J 99259 48/M 32 30 39 40 85 88 
17. K 05153 40/M 19 17 15 14 95 107 
 18. J 76696 55/M 24 25 35 37 81 86 
19. J 44175 50/M 16 14 20 18 99 97 
20. J 99230 38/M 40 40 35 38 90 95 
21. 0525-18 42/M 20 18 24 22 82 90 
22. J 89710 58/M 16 18 20 22 64 65 
23. G 42979 42/M 22 21 46 44 61 71 
24. K 13310 40/M 16 22 13 26 97 112 
25. J 68842 57/M 16 14 18 20 80 83 
26. I 04968 38/M 16 18 16 12 79 85 
27. G 67933 52/M 19 25 24 18 75 80 
28. 0524-18 34/M 16 16 16 23 43 35 
29. K 11106 60/M 20 20 25 35 90 110 
30. 0576-18 60/M 18 25 24 25 76 60 
31. I 73715 56/M 16 18 16 19 74 85 
32. G 28368 45/M 20 30 30 35 90 110 
33. J 84180 51/M 18 18 25 36 110 120 
34. K 13154 32/M 22 19 26 11 118 95 
35. K 22613 60/M 9 12 15 14 60 67 
36. I 12036 42/M 29 34 36 35 110 110 
37. K 09162 37/M 20 30 35 20 110 120 
38. 0639-18 57/M 23 20 21 19 90 85 
39. 0687-18 52/M 21 25 19 21 101 120 
40. K 25942 43/M 20 23 20 16 71 56 
 
 
S.NO
. 
 
IP/OP NO 
 
AGE / 
SEX 
TOTAL 
BILIRUBIN 
DIRECT 
BILIRUBIN 
INDIRECT 
BILIRUBIN 
BT AT BT AT BT AT 
1. 0003-17 54/M 0.8 0.8 0.2 0.2 0.6 0.6 
2. 0705-18 47/M 0.3 0.7 0.1 0.3 0.2 0.4 
3. 0043-17 44/M 0.9 0.4 0.2 0.2 0.7 0.2 
4. 0152-17 60/M 0.8 0.4 0.2 0.1 0.6 0.3 
5. 0188-17 39/F 0.7 1.0 0.3 0.2 0.4 0.8 
6. 0417-18 60/F 0.4 0.8 0.1 0.2 0.3 0.6 
7. J 76642 60/M 0.3 1.0 0.1 0.3 0.2 0.7 
8. J 71909 31/M 1.0 0.6 0.2 0.2 0.8 0.4 
9. 10040 49/M 0.6 0.5 0.2 0.2 0.4 0.3 
10. J 69785 37/M 1.0 0.3 0.2 0.1 0.8 0.2 
11. J 44174 60/M 0.7 0.9 0.2 0.2 0.5 0.7 
 12. J 82520 51/M 0.5 0.7 0.2 0.2 0.3 0.5 
13. 0052-17 45/M 0.9 0.7 0.2 0.2 0.7 0.5 
14. 8784-17 50/M 0.8 0.8 0.2 0.3 0.6 0.5 
15. J 94994 41/M 0.8 0.3 0.2 0.1 0.6 0.2 
16. J 99259 48/M 0.6 1.0 0.2 0.2 0.4 0.8 
17. K 05153 40/M 0.2 0.9 0.1 0.3 0.1 0.6 
18. J 76696 55/M 0.9 0.5 0.2 0.2 0.7 0.3 
19. J 44175 50/M 0.5 0.7 0.2 0.2 0.3 0.5 
20. J 99230 38/M 0.8 0.8 0.2 0.3 0.6 0.5 
21. 0525-18 42/M 0.8 0.7 0.2 0.3 0.6 0.4 
22. J 89710 58/M 0.9 0.5 0.2 0.2 0.7 0.3 
23. G 42979 42/M 0.7 1.0 0.2 0.3 0.5 0.7 
24. K 13310 40/M 0.8 0.3 0.3 0.1 0.5 0.2 
25. J 68842 57/M 0.5 0.8 0.2 0.3 0.3 0.5 
26. I 04968 38/M 0.9 0.5 0.2 0.3 0.7 0.2 
27. G 67933 52/M 0.2 0.7 0.1 0.2 0.1 0.5 
28. 0524-18 34/M 0.6 0.9 0.2 0.4 0.4 0.5 
29. K 11106 60/M 0.8 0.2 0.2 0.1 0.6 0.1 
30. 0576-18 60/M 0.8 0.6 0.2 0.3 0.6 0.3 
31. I 73715 56/M 0.9 1.0 0.2 0.3 0.7 0.7 
32. G 28368 45/M 0.4 0.8 0.2 0.2 0.2 0.6 
33. J 84180 51/M 0.7 1.0 0.3 0.3 0.4 0.7 
34. K 13154 32/M 1.0 0.4 0.3 0.2 0.7 0.2 
35. K 22613 60/M 0.6 0.5 0.2 0.2 0.4 0.3 
36. I 12036 42/M 1 0.7 0.2 0.3 0.8 0.4 
37. K 09162 37/M 0.3 0.8 0.1 0.3 0.2 0.5 
38. 0639-18 57/M 0.4 0.5 0.2 0.2 0.2 0.3 
39. 0687-18 52/M 0.7 0.4 0.2 0.2 0.5 0.2 
40. K 25942 43/M 0.8 0.6 0.2 0.3 0.6 0.3 
 
 
 
S. 
No. 
 
 
OP/IP No. 
 
 
AGE/
SEX 
BLOOD (mg/dl)  
 
UREA 
CREATININE 
(mg/dl) 
FASTING 
(mg/dl) 
POST 
PRANDIA
L (mg/dl) 
BT AT BT AT BT AT BT AT 
 1. 0003-17 54/M 90 96 121 125 18 17 0.8 0.8 
2. 0705-18 47/M 94 94 110 120 16 18 0.6 0.5 
3. 0043-17 44/M 100 90 101 121 20 18 0.8 0.8 
4. 0152-17 60/M 99 90 145 120 14 18 0.7 0.6 
5. 0188-17 39/F 80 84 120 100 16 18 0.8 0.8 
6. 0417-18 60/F 82 80 110 130 18 17 0.8 0.7 
7. J 76642 60/M 108 110 110 120 16 18 0.7 0.6 
8. J 71909 31/M 100 100 135 110 18 18 0.8 0.7 
9. 10040 49/M 80 90 110 120 18 18 0.8 0.6 
10. J 69785 37/M 80 90 130 130 18 16 0.8 1.0 
11. J 44174 60/M 80 85 130 110 18 18 0.7 0.7 
12. J 82520 51/M 80 95 120 135 14 16 1.0 0.8 
13. 0052-17 45/M 80 80 110 128 18 12 0.8 0.6 
14. 8784-17 50/M 90 100 130 110 16 16 0.7 0.6 
15. J 94994 41/M 80 100 120 130 16 14 0.5 0.7 
16. J 99259 48/M 93 90 120 140 16 16 0.5 1.0 
17. K 05153 40/M 90 90 182 130 16 9 1.0 0.8 
18. J 76696 55/M 80 100 100 99 16 15 0.7 0.6 
19. J 44175 50/M 85 88.5 148 110 20 18 0.8 0.7 
20. J 99230 38/M 110 90 121 120 18 16 0.8 0.7 
21. 0525-18 42/M 77 100 100 121 35 26 0.8 0.7 
22. J 89710 58/M 90 90 120 124 17 14 0.8 0.8 
23. G 42979 42/M 110 100 128 124 14 15 1.1 0.9 
24. K 13310 40/M 99 90 127 140 13 20 0.7 0.8 
25. J 68842 57/M 90 110 106 121 16 19 0.8 0.9 
26. I 04968 38/M 94 95 125 108 6 11 0.6 1.1 
27. G 67933 52/M 100 93 119 140 11 14 0.8 1.0 
 28. 0524-18 34/M 100 100 116 99 28 29 1.1 0.8 
29. K 11106 60/M 95 110 110 91 18 18 0.7 0.8 
30. 0576-18 60/M 91 91 113 110 10 7 1.0 1.6 
31. I 73715 56/M 105 100 120 129 18 16 1.0 0.1 
32. G 28368 45/M 97 103 120 126 18 19 0.8 0.8 
33. J 84180 51/M 90 110 120 130 16 16 0.8 0.9 
34. K 13154 32/M 93 100 108 140 14 14 0.8 0.8 
35. K 22613 60/M 90 86 106 79 9 12 1.0 0.8 
36. I 12036 42/M 98 86 174 193 18 16 0.7 1.0 
37. K 09162 37/M 80 75 110 130 18 18 0.4 0.7 
38. 0639-18 57/M 80 90 110 120 18 19 0.8 0.6 
39. 0687-18 52/M 90 110 120 140 17 15 1.1 1.2 
40. K 25942 43/M 95 90 115 110 20 19 0.6 0.7 
 
 
S. No. 
 
OP/IP 
NO. 
 
AGE/
SEX 
URINE 
SUGAR 
(F) 
URINE 
SUGAR 
(PP) 
 
ALBUM
IN 
DEPOSITS 
Epithelia
l cells 
Pus cells 
BT AT BT AT BT AT BT AT BT AT 
1. 0003-17 54/M Nil Nil Nil Nil Nil Nil 2-3 2-4 2-3 2-3 
2. 0705-18 47/M Nil Nil Nil Nil Nil Nil 4-6 1-2 2-3 2-6 
3. 0043-17 44/M Nil Nil Nil Nil Nil Nil 2-3 2-3 2-6 2-5 
4. 0152-17 60/M Nil Nil Nil Nil Nil Nil 4-6 2-3 2-3 2-3 
5. 0188-17 39/F Nil Nil Nil Nil Nil Nil 4-6 4-6 2-3 2-6 
6. 0417-18 60/F Nil Nil Nil Nil Nil Nil 4-6 4-6 2-3 2-3 
7. J 76642 60/M Nil Nil Nil Nil Nil Nil 4-6 4-6 2-3 2-3 
8. J 71909 31/M Nil Nil Nil Nil Nil Nil 4-6 3-5 3-5 2-3 
9. 10040 49/M Nil Nil Nil Nil Nil Nil 2-3 2-3 3-6 3-5 
 10. J 69785 37/M Nil Nil Nil Nil Nil Nil 3-6 3-6 2-3 5-6 
11. J 44174 60/M Nil Nil Nil Nil Nil Nil 4-6 3-6 2-3 2-4 
12. J 82520 51/M Nil Nil Nil Nil Nil Nil 3-5 4-5 1-2 3-4 
13. 0052-17 45/M Nil Nil Nil Nil Nil Nil 4-6 2-4 2-3 1-2 
14. 8784-17 50/M Nil Nil Nil Nil Nil Nil 4-6 4-5 2-3 3-4 
15. J 94994 41/M Nil Nil Nil Nil Nil Nil 3-5 4-6 2-3 3-4 
16. J 99259 48/M Nil Nil Nil Nil Nil Nil 3-5 4-6 4-6 4-5 
17. K 05153 40/M Nil Nil Nil Nil Nil Nil 1-2 3-5 2-6 2-3 
18. J 76696 55/M Nil Nil Nil Nil Nil Nil 4-6 2-3 2-3 6-7 
19. J 44175 50/M Nil Nil Nil Nil Nil Nil 2-3 4-6 2-3 2-3 
20. J 99230 38/M Nil Nil Nil Nil Nil Nil 2-5 2-3 2-3 2-4 
21. 0525-18 42/M Nil Nil Nil Nil Nil Nil 4-6 4-6 2-4 3-5 
22. J 89710 58/M Nil Nil Nil Nil Nil Nil 2-4 4-8 1-2 1-2 
23. G 42979 42/M Nil Nil Nil Nil Nil Nil 1-2 2-4 1-2 1-3 
24. K 13310 40/M Nil Nil Nil Nil Nil Nil 3-6 1-2 2-4 1-2 
25. J 68842 57/M Nil Nil Nil Nil Nil Nil 3-6 3-5 2-4 2-4 
26. I 04968 38/M Nil Nil Nil Nil Nil Nil 1-2 1-2 2-3 2-4 
27. G 67933 52/M Nil Nil Nil Nil Nil Nil 2-4 1-2 2-4 2-5 
28. 0524-18 34/M Nil Nil Nil Nil Nil Nil 2-4 6-8 2-4 8-
10 
29. K 11106 60/M Nil Nil Nil Nil Nil Nil 4-6 4-6 2-3 2-3 
30. 0576-18 60/M Nil Nil Nil Nil Nil Nil 1-2 1-2 1-2 3-5 
31. I 73715 56/M Nil Nil Nil Nil Nil Nil 2-6 4-6 4-5 3-5 
32. G 28368 45/M Nil Nil Nil Nil Nil Nil 2-3 2-4 4-6 4-6 
33. J 84180 51/M Nil Nil Nil Nil Nil Nil 4-6 4-6 2-3 3-5 
34. K 13154 32/M Nil Nil Nil Nil Nil Nil 2-3 2-4 1-2 2-4 
35. K 22613 60/M Nil Nil Nil Nil Nil Nil 3-5 2-3 3-5 1-2 
 36. I 12036 42/M Nil Nil Nil Nil Nil Nil 4-6 2-3 4-6 2-3 
37. K 09162 37/M Nil Nil Nil Nil Nil Nil 4-6 2-6 2-3 3-4 
38. 0639-18 57/M Nil Nil Nil Nil Nil Nil 4-6 5-6 2-3 2-3 
39. 0687-18 52/M Nil Nil Nil Nil Nil Nil 4-6 4-6 2-3 2-3 
40. K 25942 43/M Nil Nil Nil Nil Nil Nil 1-2 2-4 2-4 2-4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION
  
 
 
DISCUSSION 
Silaipun  (Varicose ulcer) is one of the late manifestations of  chronic venous 
insufficiency (CVI) of the lower limbs, a disease of great importance to public health due to its 
high incidence and prevalence. This condition is difficult to treat and needs complete rest (leg 
elevation). 
The trial drugs were prepared in Gunapadam lab of National institute of Siddha after the 
authentication of the raw drugs by Assistant professor of medicinal botany, NIS, Chennai. The 
trial drugs were prepared by standard operating procedure as mentioned in the protocol. 
The bio-chemical analysis was done at the biochemistry lab of NIS and the results were 
documented. The bio-chemical analysis of Elathy chooranam had  shown the presence of 
reducing sugar, starch and alkaloids. 
The clinical study was conducted with a well-defined protocol and a proper proforma 
after the approval of Institutional Ethical Committee. 
For this dissertation study, 40 patients were selected and the patients were treated in the 
OP/IP department of  Sirappu maruthuvam, in Ayothidoss pandithar hospital-National Institute 
of Siddha, Tambaram Sanatorium, Chennai-47. 
Based on various criteria, the data were collected and tabulated. The criteria were family 
history, sex predominance, age distribution, occupation, dietary habits and incidence of the 
disease with reference to thinai, seasonal variation, clinical manifestations and assessment of the 
improvement in the prognosis of the disease with the trial drug. 
In Siddha system, it is necessary to bring the vitiated humours to equilibrium. Hence 
before the treatment agasthiyar kuzhambu with sangankuppi juice (Cleodendrum inerme) was 
given for viresanam (purgation) in the early morning to normalize the vitiated humours. During 
the treatment, the patients were adviced to follow pathiyam (dietary regimen). 
Internal drug:  Elathy chooranam – 1.5  gm two times per day with milk 
External drug:  Pathirasara virana poochu thailam for external application. 
Duration of  drug:  45 days 
40 patients of both genders were recruited for this study. Among the 40 patients, 38 
patients (95%) were males and 2 patients (5%) were females.  
 In  this  trial  40  cases  were selected.  Among 40  patients, 10  patients (25%) between 31 
and 40 years, 13 patients (32.5%) between 41 and 50 years, 17 patients (42.5%) between 51 and 
60 years. In this present study, considerable numbers of patients were reported (17 patients) 
between the age of 51 and 60 years among study sample. 
Among 40 cases recruited to this study, 6 number of cases had family history of varicose 
ulcer (VU). Recent studies regarding varicose ulcer also emphasize on this concept that VU has a 
genetic predisposition. 
In this study only 2 patients were vegetarian, and remaining  patients were non vegetarian. 
In this present study, 33 patients were reported from Neithal (82.5%) and 7 patients were 
from Marutham (17.5%). 18 patients were admitted during Pinpani Kaalam (Maasi & Panguni) 
while in munpani kaalam (Maargali & Thaii), ilavenil kaalam (Chitthirai & Vaigasi) and koothir 
kaalam (Ippasi & Karthikai) 7,11 and 4 patients were admitted respectively. 
Based on the Kaalam (age), 37 patients (92.5%) were affected at pitha kaalam (age 
between 34 to 66 years) while 3 patients (7.5%) were affected at vatha kalam (age between 1 to 
33 years). 
Varicose ulcer with various sizes were selected randomly for the trial. 24 patients (60%) 
had ulcer more than one year while 3 patients (7.5%) had ulcer within 3 months and between 7 to 
9 months duration separately. 5 patients (12.5%) had ulcer between 4 to 6 months and 10 to 12 
months duration each. 
Among 40 cases, all cases had ulcer and hyperpigmentation around the ulcer. Itching, 
fibrinous exudate and swelling were seen in 70-80% of patients which were markedly reduced 
after the treatment. Eczema, inflammation and induration were seen in 20 -25% patients. 
Laboratory investigations were done for all the cases before and after treatment. There 
were no variations in hepatic, renal and other parameters. 
The outcome of this study was clinically observed by VCSS, which showed encouraging 
results of good improvement in 13 patients (32.5%) , moderate improvement in 5 patients (12.5%), 
mild improvement in 15 patients (37.5%) and poor improvement in 7 patients (17.5%) of total 40 
cases. 
The mean± standard deviation of  VCSS   before and after treatment were 12.15±2.92 and 
6.63±4.14 respectively which is considered extremely significant (t=13.97, p=0.0001). 
 
 In this study, no adverse events were observed during the course of the treatment. At the 
time of discharge, all the patients were advised to attend Out-Patient Department of Sirappu 
Maruthuvam of NIS for 2 months for follow-up treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
SUMMARY 
  
 
 
SUMMARY 
The disease silaipun was taken for the clinical study with Elathy Chooranam as internal 
medicine and Pathirasara virana poochu thailam as external application. For the clinical study, 
40 cases were selected based on the approved protocol. 
The trial was approved by the Institutional Ethical Committee (IEC) (Date of IEC 
Approval & its Number; NIS/IEC/2016/11-11/14.10.2016). The trial was registered in Clinical 
Trial Registry of India (CTRI/2018/04/013087). Hence the study is safely executed on patients 
and there was no adverse drug reactions noted during the study period. 
Out of the 40 cases, 20 cases were treated in OPD and remaining 20 cases were treated in 
IPD of Ayothidoss Pandithar Hospital of National Institute of Siddha, Chennai-47. The detailed 
study on silaipun with reference to its aetiology, pathogenesis, investigations, clinical features, 
diagnosis and treatment with trial drugs was done. 
The outcome results of my study was clinically observed by Venous Clinical Severity Score 
(VCSS) that is 32.5% of cases had shown good improvement, 12.5% of cases had shown moderate 
improvement, 37.5% of cases had shown mild improvement and remaining 17.5%  had shown poor 
improvement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
CONCLUSION 
  
 
CONCLUSION 
This clinical study validated the Siddha herbal formulation of the trial drug 
“Elathy Chooranam” is efficacy to Varicose ulcer patients. It was found to be effective 
on silaipun patients in reducing clinical signs and symptoms like pain, itching and size of 
the ulcer. The literature evidence for this drug is Siddha vaidhya thirattu which is well-
known Shasthric preparation. 
In this study, no adverse reactions were reported. Hence, it is concluded that the 
trial drugs are clinically safe. 
The cost of the trial medicines are low. These drugs are easily available and the 
dosage is also convenient. 
The quantitative outcome of VCSS is statistically significant  between  the 
commencement and end of the treatment i.e from 12.15 ± 2.92 to 6.63 ± 4.14. The 
qualitative outcome shows there is 32.5% of cases shown good improvement, 12.5% of 
cases shown moderate improvement, 37.5 % shown mild improvement and 17.5% of cases 
shown poor improvement.  
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
    TO EVALUATE  THE THERAPEUTIC EFFICACY  OF ELATHY CHOORANAM (INTERNAL 
MEDICINE) AND PATHIRASARA VIRANA POOCHU THAILAM (EXTERNAL MEDICINE ) IN 
THE TREATMENT OF SILAIPUN (VARICOSE ULCER). 
Principal Investigator: Dr.Pon.Loganathan. 
FORM l - SCREENING & SELECTION PROFORMA  
 SL.NO                                     OP NO:   
 NAME:                                                    AGE/GENDER:                CONTACT NO: 
 
INCLUSION CRITERIA 
 
1) Age :20-60Yrs                                                                                               Yes/ No 8) Fibrunous exudate 
 
Yes/ No 
2) Sex M/F 9) Skin pigmentation 
 
Yes/ No 
3) Ulcer Yes/ No 10) Inflammation 
 
Yes/ No 
4) Pain Yes/ No 11) Induration                                                                                                             
 
Yes/No 
5) Edema 
 
Yes/ No 12) Itching 
 
Yes/No 
s6) Eczema around 
ulcer 
 
Yes/ No 13) Permit to take 
photograph 
Yes/ No 
7) Willing to give 
blood for investigation 
Yes/ No 14) Willing to participate in 
trial and signing consent by 
fulfilling the condition of   
Proforma. 
          
Yes/ No 
 
Patient satisfying minimum 8 criteria will be included in the clinical trial. 
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EXCLUSION CRITERIA: H/O 
Diabetes mellitus Yes/No Gangrene 
 
Yes/ No 
Tuberculous ulcer Yes/No Any other systemic illness Yes/No 
HIV Yes/No Hanson’s disease Yes/No 
Diabetic ulcer    
 
ADMITTED TO TRIAL:  YES   NO                         If yes,    serial No: 
                   OPD                  IPD 
 
 
Date:        
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                              Signature of the HOD  
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
    TO EVALUATE  THE THERAPEUTIC EFFICACY  OF ELATHY CHOORANAM (INTERNAL 
MEDICINE) AND PATHIRASARA VIRANA POOCHU THAILAM (EXTERNAL MEDICINE ) IN 
THE TREATMENT OF SILAIPUN (VARICOSE ULCER). 
Principal Investigator: Dr.Pon.Loganathan. 
FORM II – CLINICAL RESEARCH FORM 
 STUDY NO                                                                          OP / IP NO:    
 NAME:                                                                                 AGE/GENDER:  
 ADDRESS:                                                                           CONTACT NO: 
                                                                                                 RELIGION:  H / M / C / O          
OCCUPATION:                                                                     INCOME: 
MARRITAL STATUS:    MARRIED                                 UNMARRIED         
DATE OF INITIAL ASSESSMENT:                                       
COMPLAINTS & DURATION:                                                                                                                                                                                        
PERSONAL HISTORY: 
         PERSONAL HABITS YES NO IF YES SPECIFY 
DURATION 
AMOUNT/
Qty 
             Smoking     
           Tobacco Chewing     
            Alcohol     
          Narcotic  Drug Addiction     
 
HISTORY OF PREVIOUS ILLNESS AND TREATMENT TAKEN: 
 FAMILY HISTORY: 
 Whether this problem runs in family?         1. Yes                               2.No         
            If yes, mention the relationship of affected person(s) 
1._________________ 
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 2._________________ 
DIETARY HABIT:     
                    1.Vegetarian                                              2.Non-vegetarian 
 MENSTURAL HISTORY AND OBSTETRIC HISTORY: 
FORM II a 
GENERAL EXAMINATION: 
1. Body weight [Kg]    :                      
2. Height [cms]                             :                        
3. Body Temperature [0F]       :   
4. Blood Pressure (mm/Hg)  :      
5. Pulse Rate /min.        : 
6. Heart Rate / min.         : 
7. Respiratory Rate /min.  :   
                                                                                                  Yes            No   
8. Pallor  :   
9. Jaundice  :   
10. Clubbing  : 
11. Cyanosis  : 
12. Pedal Oedema  : 
13. Lymphadenopathy           :  
14. Jugular venous pulsation        :   
 
 VITAL ORGANS EXAMINATION:         Normal          Abnormal 
1.  Heart 
2. Lungs  
3. Brain 
4. Liver 
5. Kidney 
6. Spleen 
7. Stomach   
 
SYSTEMIC EXAMINATION:                   Normal          Abnormal 
1. Cardio-vascular system 
2. Respiratory system         
3. Gastro intestinal system 
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4. Central nervous system 
5.  Uro-genital system     
6.  Endocrine system        
 
SIDDHA SYSTEM OF EXAMINATION  
1. THEGI (TYPE OF BODY CONSTITUTION): 
1. Vaatha udal                                          3. Kaba udal                   
2. Pitha udal                                          4. Thontha udal 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji                                            3. Paalai 
2. Mullai                                             4. Neithal 
5. Marutham 
3. KAALAM: 
1. Kaar kaalam                                          4. Pinpani kaalam 
2. Koothir kaalam                                       5. Ilavenil kaalam 
3. Munpani kaalam                                     6. Muthuvenil kaalam 
4. GUNAM: 
1. Sathuvam                                                 2. Rasogunam 
3. Thamogunam 
 
5. PORIPULANGAL (SENSORY ORGANS): 
 1th day 8th day 15th 
day 
22nd 
day 
29th 
day 
36th 
day  
43rd 
Day 
46th 
day 
Mei (skin)         
Vaai(tongue)         
Kan (eye)         
Mooku(nose)         
Sevi (ear)         
 
6. KANMENDRIYAM (MOTOR ORGANS): 
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 1th day 8th day 15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 
46th 
day 
Kai(upper limb)         
Kaal(lower limb)         
Vaai(speech)         
Eruvai 
(excretory organ) 
        
Karuvai 
(reproductive 
organs) 
        
 
7. KOSANGAL (SHEATH):          
 1th day 8th day 15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 
46th 
day 
AnnamayaKos
am 
        
Pranamayakos
am  
        
Manomaya 
kosam  
        
Vignanamaya 
kosam  
        
Aananthamay
akosam  
        
 
8.UYIR THATHUKKAL (THREE HUMOURS): 
A. VALI 
 1th day 8thday 15th 
day 
22nd 
day 
29th 
day 
36th day 43rd   
day 
46th day 
Praanan         
Abaanan         
Viyaanan         
Udhaanan         
Samaanan         
Naagan         
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Koorman         
Kirukaran         
Devathathan         
Dhananjeyan         
 
 
 
 
 
B) AZHAL 
 1th day 
8th 
 Day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd  
day 
46th  
day 
Analakam         
Prasakam  
        
Ranjakam 
        
Aalosakam 
        
Saathakam         
 
 
C. IYAM:             
 1th day 8th day 15th 
day 
22nd 
day 
29thday 36thday 43rd  
day 
46th 
day 
Avalambagam         
Kilethagam         
Pothagam         
Tharpagam
  
        
Santhigam
  
        
 
9.SEVEN UDAL DHATHUS: (7 SOMATIC COMPONENTS)  
 1th day 8thday 15thday 22nd 
day 
29thday 36th  
day 
43rd 
day 
46th  
day 
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Saaram         
Senneer          
Oon         
Kozhuppu         
Enbu         
Moolai         
Sukkilam / 
Suronitham  
        
ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION]  
I. NAADI: [PULSE PERCEPTION] 
II. SPARISAM: 
1th Day 8th Day 15th Day 22nd day 29th day 36th day 43rd day 46th day 
        
III. NAA:[TONGUE] 
1th Day 8th Day 15th Day 22nd Day 29th Day 36th Day 43rd Day 46th Day 
        
 
VI.NIRAM: [COMPLEXION]   
     1. Vaatham                                              3. Kabam 
     2. Pitham 
 
V.MOZHI: [VOICE] 
1. High Pitched                                     2. Low Pitched 
      3. Medium Pitched 
VI.VIZHI: [EYES]  
1th Day 8th Day 15th Day 22th Day 29th Day 36th Day 43rd Day 46th Day 
        
VII. MALAM: [BOWEL HABITS / STOOLS] 
1th Day 8th day 15thday 22ndday 29th day 36th day 43rd day 46th day 
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     Before treatment After treatment 
Niram   
Irugal   
Ilagal   
Others   
 
 
 VIII. MOOTHIRAM [URINE EXAMINATION]   
Neerkkuri Before treatment After treatment 
Niram 
 
  
Manam   
Edai   
Nurai   
Enjal   
 
NEIKURI Before treatment After  treatment 
Aravu (Serpentine fashion)   
Aazhi (Annular/Ringed fashion)   
Muthu (Pearl beaded fashion)   
Kalappu (Mixed fashion)   
Other fashion   
CLINICAL EXAMINATION:                  
CLINICAL EXAMINATION OF SKIN 
1.Site:     -----------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------- 
2. Colour:           Normal           Reddish                Black               Greyish 
3. Shape:               Irregular           Regular              Champagne bottle shape 
4. Itching:  No                   Mild                    Moderate                   Severe 
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5. Fibrinous exudate: No                  Mild                      Moderate               Severe 
6. Erythema:  Present   Absent 
7. Bleeding:    Present                 Absent 
8. Crusting:   Present                Absent  
9. Lichenification:              Present                  Absent 
      10. Varicose vein:              Present                           Absent 
      11. Venous edema:            Present                           Absent 
       12. Inflammation:             Present                            Absent 
       13. Induration:                 Present                           Absent 
                                                                                                                  
                  YES                               NO 
 14. Ulcération:  
 15. Macule:   
 16. Papule: 
 17. Pustule:  
       18. Blister: 
 19. Vesicle :   
 20. Pigmentation:                        Hypo                       Hyper  
FORM II B-CLINICAL ASSESSMENT DURING AND AFTER TRIAL 
 OP/ IP NO:                               STUDY NO:              NAME: 
 AGE/GENDER:               DATE OF RECRUITMENT: 
 Day 1 After 7 
days 
After 
14 days 
After 
21days 
After 
28 days 
After 
35 days 
After 
42 days 
After 
46 days 
 Ulcers with 
varicose vein 
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Fibrunous 
exudate 
 
        
Itching         
Edema 
 
        
Skin 
pigmentation 
        
Eczema around 
the ulcer 
Itching 
        
Inflammation 
 
        
Induration         
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                       Signature of the HOD 
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                                          NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSSPANDITHARHOSPITAL 
CHENNAI – 600 047. 
POST-GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
       TO EVALUATE  THE THERAPEUTIC EFFICACY  OF ELATHY CHOORANAM(INTERNAL 
MEDICINE) AND PATHIRASARA VIRANA POOCHU THAILAM(EXTERNAL MEDICINE ) IN 
THE TREATMENT OF SILAIPUN (VARICOSE ULCER). 
Principal Investigator: Dr.Pon.Loganathan. 
FORM-III – LABORATORY INVESTIGATIONS PROFORMA 
STUDY NO:                       OP / IP NO:                                     AGE/GENDER:    
BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE 
TMT  
( DATE) 
AFTER TMT 
(DATE) 
Hb( gm/dl) 
M:12-15 
F:11.5-14 
  
T.WBC (cells/cu.mm) 
4000-
11000 
  
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-40   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
T.RBC(million cells/cu.mm) M:4.0-5.5 
  F:3.5-4.5 
  
  ESR(mm/hour) ½ hr. M:1-13 
F:1-20 
  
  1 hr.   
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Blood Investigations Normal Values 
Before TMT 
(DATE) 
After TMT 
(DATE) 
Blood 
glucose 
(mg/dl) 
Fasting    70-110   
PP    80-140   
Random    80-120   
RFT 
(mg/dl) 
Blood urea    16-50   
Serum creatinine    0.6-1.2   
Serum uric acid M:3-9  F:2.5-7.5   
LFT 
(mg/dl) 
Total bilirubin    0.2-1.2   
Direct bilirubin    0.1-1.2   
Indirect bilirubin    0.2-0.7   
SGOT  (IU/L)    0-40   
SGPT (IU/L)    0-35   
Alkaline 
phosphatase(IU/L) 
   80-290   
          
Station:       
Signature of the Investigator: 
Signature of the Lecturer:            Signature of the HOD 
 
 
 
Urine 
investigations 
Before TMT( Date) After TMT ( Date) 
Albumin   
Fasting sugar   
PP sugar   
Deposits   
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                                            NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST-GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
     TO EVALUATE  THE THERAPEUTIC EFFICACY  OF ELATHY CHOORANAM(INTERNAL 
MEDICINE) AND PATHIRASARA VIRANA POOCHU THAILAM(EXTERNAL MEDICINE ) IN 
THE TREATMENT OF SILAIPUN (VARICOSE ULCER). 
Principal Investigator: Dr.Pon.Loganathan. 
FORM IV (DRUG COMPLIANCE FORM) 
STUDY NO                OP / IP NO:               NAME:                                            
AGE/GENDER:  
DRUG NAME:           
On 1st     day-Date:  Drugs issued:  (Gms) Drugs returned:    (Gms) 
On 8th  day-Date:   Drugs issued:  (Gms) Drugs returned:    (Gms) 
On 15th day-Date:              Drugs issued:  (Gms) Drugs returned:    (Gms) 
On 22ndday-Date:  Drugs issued:  (Gms) Drugs returned:    (Gms) 
On 29th day-Date:   Drugs issued:  (Gms) Drugs returned:    (Gms) 
On 36thday-Date:              Drugs issued:  (Gms) Drugs returned:    (Gms) 
On 43rd day-Date:  Drugs issued:  (Gms) Drugs returned:    (Gms) 
On 46th   day-Date:   Drugs issued:  (Gms) Drugs returned:    (Gms) 
 
 
 
Date Morning Evening Day Date Morning Evening 
Day 1    Day25    
Day2    Day26    
Day3    Day27    
Day4    Day28    
Day5    Day29    
Day6    Day30    
Day7    Day31    
Day 8    Day32    
Day9    Day33    
Day10    Day34    
Day11    Day35    
Day12    Day36    
Day13    Day37    
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Station:       
Signature of the Investigator: 
Signature of the Lecturer:            Signature of the HOD 
 
 
 
 
 
Day14    Day38    
Day15    Day39    
Day16    Day40    
Day17    Day41    
Day18    Day42    
Day19    Day43    
Day20    Day44    
Day21    Day45    
Day22    Day46    
Day23        
Day24        
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FORM V – PATIENT INFORMATION SHEET 
Name of Principal Investigator: Dr.Pon.Loganathan, 
Name of the institute: National Institute of Siddha, 
                Tambaram Sanatorium, Chennai-47. 
I, Dr.Pon.Loganathan studying M.D(Siddha) at National Institute of  Siddha, 
Tambaram Sanatorium is doing a trial on SILAIPUN (Varicose ulcer).Varicose ulcer is a 
most common persistent skin disease, occurring throughout the world. In this regard, I am 
in a need to ask you few questions. I will maintain confidentiality of your comments and 
data obtained. There will be no risk of disclosing your identity and no physical, 
psychological or professional risk is involved by taking part in this study. Taking part in 
this study is voluntary. No compensation will be paid to you for taking part in this study. 
           You can choose not to take part. You can choose not to answer a specific question. 
There is no specific benefit for you if you take part in the study. However, taking part in 
the study may be of benefit to the community, as it may help us to understand the problem 
of defaulters and potential solutions. 
             If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal medicine 
ELATHY CHOORANAM (Internal medicine-1.5g BD for 45 days) and PATHIRASARA 
VIRANA POOCHU THAILAM  (External medicine), if you wish to stay in the In-Patient 
ward Treatment will be provided to you assuring that you will not be definitely hurt in any 
course of treatment. 
 The information I am collecting in this study will remain confidential. I will ask 
you few questions through a questionnaire. It will take approximately 20 min of time. Your 
name won’t be mentioned in the lab investigation form instead a code will be used. 
If you wish to find out more about this study before taking part, you can ask me all 
the questions you want or contact Dr.Pon.Loganathan, PG Scholar cum principal 
investigator of this study, National Institute of Siddha, Chennai-47. You can also contact 
the Member-secretary of Ethics committee, National Institute of Siddha, Chennai 600047, 
and Tel No: 044-22380789 for rights and participation in the study. 
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
          «§Â¡ò¾¢¾¡Š ÀñÊ¾÷ ÁÕòÐÅÁ¨É - ¦ºý¨É 47 
º¢¨ÄôÒñ §¿¡öì¸¡É º¢ò¾ ÁÕóÐ¸Ç¢ý (²Ä¡¾¢ ÝÃ½õ ÁüÚõ Àò¾¢Ãº¡Ã 
Å¢Ã½ âîÍ ¨¾Äõ) ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø 
ÀÊÅõ. 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷: ÁÕòÐÅ÷ : ¦À¡ý.§Ä¡¸¿¡¾ý 
¿¢ÚÅÉò¾¢ý ¦ÀÂ÷ :  §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ                            
§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ ÅÕõ ¿¡ý ÁÕòÐÅ÷ 
¦À¡ý.§Ä¡¸¿¡¾ý, º¢¨ÄôÒñ ±ýÛõ §¿¡Â¢ø ÁÕòÐÅ ¬Ã¡öîº¢Â¢ø 
®ÎÀðÎû§Çý. Òñ ±ýÛõ §¿¡ö ¯ñ¼¡Å¾ü¸¡É «ÊôÀ¨¼ ¸¡Ã½õ ¸¢ÕÁ¢¸û 
«ýÚ. ¸ðÊ ¯¨¼Å¾É¡Öõ, ¸ÕÅ¢Â¢É¡Öõ, «ÊÀÎÅ¾¡Öõ, ¦¿ÕôÀ¢É¡Öõ, À¢È 
¯Â¢÷¸Ç¢ý ¸Ê¸Ç¡Öõ ¯ñ¼¡Å¾¡¸ ÜÈôÀÎ¸¢ÈÐ. -Ð ÀÃÅ ÜÊÂ §¿¡ö «ýÚ. 
-ó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç §¸ð¸×õ, §¾¨ÅÂ¡É ¬öÅ¸ 
ÀÃ¢§º¡¾¨ÉìÌ ¾í¸¨Ç ¯ ðÀÎò¾×õ ¯ û§Çý.-Ð ºõÀó¾Á¡É ¾í¸ÇÐ «¨ÉòÐ 
Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ ±É ¯Ú¾¢ «Ç¢ì¸¢§Èý. -¾¢ø ÀÂ½ôÀÊ 
Ó¾Ä¢Â ±ó¾ ¯¾Å¢ò ¦¾¡¨¸Ôõ ÅÆí¸ôÀ¼ Á¡ð¼¡Ð. -ó¾ ¬Ã¡öîº¢Â¢ý §À¡Ð 
¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ²üÀÎõ Àðºò¾¢ø §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ¾ì¸ 
º¢¸¢î¨º «Ç¢ì¸ôÀÎõ.-ó¾ ¬Ã¡öîº¢ìÌ ¾¡í¸û Å¢ÕôÀò¾¢ý §ÀÃ¢ø ¯ðÀÎõ 
Àðºò¾¢ø ¯ ûÁÕó¾¡¸ ²Ä¡¾¢ ÝÃ½õ (1.5gm) 2 §Å¨Ç (¸¡¨Ä,Á¡¨Ä) ¯ ½×ìÌô 
À¢ý 45 ¿¡ð¸û ¯ð¦¸¡ûÇ §ÅñÎõ. ¦ÅÇ¢ ÁÕó¾¡¸ Àò¾¢Ãº¡Ã Å¢Ã½ âîÍ 
¨¾Äõ  ¦ÅÇ¢§Â ¾¼Å §ÅñÎõ. ¦ÅÇ¢ §¿¡Â¡Ç÷¸û 7 ¿¡ð¸ÙìÌ ´ÕÓ¨È 
ÁÕòÐÅÁ¨ÉìÌ ÅÃ§ÅñÎõ. ¯û §¿¡Â¡Ç¢Â¡¸ ¾í¸ Å¢ÕôÀõ ¦¾Ã¢Å¢ìÌõ 
Àðºò¾¢ø §¿¡öìÌ ¾Ìó¾  º¢¸¢î¨º «Ç¢ì¸ôÀÎõ. -ó¾ ¬Ã¡öîº¢Â¢ø §¿¡Â¢ÉÃ¡¸ 
§º÷ó¾ À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀõ -ø¨Ä¦ÂÉ¢ø ±ô§À¡Ð §ÅñÎÁ¡É¡Öõ Å¢Ä¸¢ 
¦¸¡ûÇÄ¡õ. -ó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ ÁüÈ Å¢ÀÃí¸ÙìÌõ §¿¡Â¢ý ¾ý¨Á 
ÀüÈ¢Ôõ Ó¾ý¨Á ¬Ã¡öîº¢Â¡ÇÃ¡É ÁÕòÐÅ÷: ¦À¡ý.§Ä¡¸¿¡¾ý (Àð¼ §Áü 
ÀÊôÀ¡Ç÷ º¢ÈôÒ ÁÕòÐÅ Ð¨È) «Ï¸×õ. ¨¸ô§Àº¢ ±ñ 7418240820. §ÁÖõ  -ó¾ 
¬Ã¡öîº¢ìÌ IEC º¡ýÚ ¦ÀÈôÀðÎûÇÐ. -ó¾ ÁÕóÐ º¢ÈôÀ¡¸ Òñ §¿¡öì¸¡¸ 
«í¸£¸Ã¢ì¸ôÀð¼ º¢ò¾ ÁÕòÐÅ áÄ¢ø ÜÈôÀðÎûÇÐ. ²ü¸É§Å ¯À§Â¡¸ò¾¢ø 
¯ûÇ -Ð §À¡ýÈ ÁÕóÐ -ÐÅ¨Ã §¿¡Â¡Ç¢¸Ç¢¼õ ±ó¾ Å¢¾ Àì¸ Å¢¨Ç×¸¨ÇÔõ 
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²üÀÎò¾Å¢ø¨Ä. §ÁÖõ ¯½× Ó¨ÈÂ¢ø ÁÕòÐÅÃ¡ø ÜÈôÀÎõ Àò¾¢Âõ ¸¡ìÌÁ¡Ú 
«È¢×Úò¾ôÀÎ¸¢ÈÐ. 
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                               NATIONAL INSTITUTE OF SIDDHA 
 AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
        TO EVALUATE  THE THERAPEUTIC EFFICACY  OF ELATHY 
CHOORANAM(INTERNAL MEDICINE) AND PATHIRASARA VIRANA POOCHU 
THAILAM(EXTERNAL MEDICINE ) IN THE TREATMENT OF SILAIPUN ( VARICOSE 
ULCER). 
FORM VI: INFORMED CONSENT FORM 
“I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions I have asked have been answered 
to my satisfaction.  
            I   consent voluntarily to participate in this study and understand that I have the 
right to withdraw from the study at any time without affecting my further medical care”. 
"I have received a copy of the information sheet/consent form". 
Signature of the participant: 
In case of illiterate participant 
  “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm that 
the individual has given consent freely.”                                                   
 
Date: 
Signature of a witness                                                          Left thumb Impression  
                                                                                              Of the Participant     
(Selected by the participant bearing no connection with the survey team)   
Signature of the Investigator 
 
 Signature of the Lecturer                                                       Signature of the HOD 
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
«§Â¡ò¾¢¾¡Š ÀñÊ¾÷ ÁÕòÐÅÁ¨É-¦ºý¨É 47 
´ôÒ¾ø ÀÊÅõ                        
º¢¨ÄôÒñ  §¿¡öì¸¡É º¢ò¾ ÁÕóÐ¸Ç¢ý  (²Ä¡¾¢ ÝÃ½õ ÁüÚõ Àò¾¢Ãº¡Ã 
Å¢Ã½ âîÍ ¨¾Äõ) ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É 
´ôÒ¾ø ÀÊÅõ-¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð. 
   ¿¡ý -ó¾ ¬ö× ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌ ÒÃ¢Ôõ Å¨¸Â¢ø 
±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
 §¾¾¢:                                                     ¨¸¦Â¡ôÀõ: 
-¼õ:                                                      ¦ÀÂ÷     : 
                                         §¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
±ýÉ¢¼õ -ó¾ ÁÕòÐÅ ¬öÅ¢ý ¸¡Ã½ò¨¾Ôõ, ÁÕó¾¢ý ¾ý¨Á ÁüÚõ 
ÁÕòÐÅ ÅÆ¢Ó¨È ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ ±ÉÐ ¯¼ø -Âì¸ò¨¾ ¸ñ¸¡½¢ì¸×õ, 
«¾¨É À¡Ð¸¡ì¸×õ ÀÂýÀÎõ ÁÕòÐÅ ¬ö×ìÜ¼ ÀÃ¢§º¡¾¨É¸û ÀüÈ¢   ¾¢Õô¾¢ 
«Ç¢ìÌõ Å¨¸Â¢ø ¬ö× ÁÕòÐÅÃ¡ø Å¢Çì¸¢ì ÜÈôÀð¼Ð. 
¿¡ý -ó¾ ÁÕòÐÅ ¬öÅ¢ý §À¡Ð, ±ô¦À¡ØÐ §ÅñÎÁ¡É¡Öõ -ó¾ ¬öÅ¢Ä¢ÕóÐ   
±ý¨É Å¢ÎÅ¢òÐ ¦¸¡ûÙõ ¯Ã¢¨Á¨Â ¦¾Ã¢ó¾¢Õì¸¢ý§Èý. ¿¡ý ±ýÛ¨¼Â 
Í¾ó¾¢ÃÁ¡¸ §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âì ¦¸¡ñÎ  º¢¨ÄôÒñ §¿¡öì¸¡É ²Ä¡¾¢ 
ÝÃ½õ (¯û ÁÕóÐ) ÁüÚõ Àò¾¢Ãº¡Ã Å¢Ã½ âîÍ ¨¾Äõ (¦ÅÇ¢ ÁÕóÐ) 
ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢üÌ ±ý¨É ¯ðÀÎò¾ 
´ôÒ¾ø «Ç¢ì¸¢§Èý. 
§¾¾¢:                                                  ¨¸¦Â¡ôÀõ: 
-¼õ:       ¦ÀÂ÷ :     
¯È×Ó¨È:                                          º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ: 
¦ÀÂ÷:     
Å¢Ã¢×¨ÃÂ¡Ç÷    ¨¸¦Â¡ôÀõ:                           Ð¨Èò¾¨ÄÅ÷ ¨¸¦Â¡ôÀõ 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
 DEPARTMENT OF SIRAPPU MARUTHUVAM 
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    TO EVALUATE  THE THERAPEUTIC EFFICACY  OF ELATHY 
CHOORANAM(INTERNAL MEDICINE) AND PATHIRASARA VIRANA POOCHU 
THAILAM(EXTERNAL MEDICINE ) IN THE TREATMENT OF SILAIPUN ( VARICOSE 
ULCER). 
 
Name of Principal Investigator: Dr.PON.LOGANATHAN.   
 
FORM VII - WITHDRAWAL FORM 
 
1. SERIAL NO OF THE CASE:    
2. OP / IP NO:     
3. NAME:      
4. AGE:         
5. GENDER:                          
6. DATE OF TRIAL COMMENCEMENT:  
7. DATE OF WITHDRAWAL FROM TRIAL:  
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes/ No 
Irregular treatment:                           Yes/ No 
Shift of locality:                                     Yes/No 
Increase in severity of symptoms:     Yes/No 
Development of severe adverse drug reactions:   Yes/No 
Development of adverse event:                                              Yes/No 
(If YES, give the details of adverse reaction in Form VII -B – Adverse      
Reaction Form / Pharmaco Vigilance Form) 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                          Signature of the HOD 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
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    TO EVALUATE  THE THERAPEUTIC EFFICACY  OF ELATHY CHOORANAM(INTERNAL 
MEDICINE) AND PATHIRASARA VIRANA POOCHU THAILAM(EXTERNAL MEDICINE ) IN 
THE TREATMENT OF SILAIPUN (VARICOSE ULCER). 
Name of Principal Investigator: Dr.PON.LOGANATHAN.     
 
FORM VII - A – ADVERSE REACTION FORM / PHARMACO VIGILANCE 
FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                             AGE:                     GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF THE ADVERSE REACTION OCCUR: 
DESCRIPTION OF ADVERSE REACTION: 
 
 
 
 
 
 
 
 
 
 
 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                            Signature of the HOD 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
 DEPARTMENT OF SIRAPPU MARUTHUVAM 
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    TO EVALUATE  THE THERAPEUTIC EFFICACY  OF ELATHY CHOORANAM (INTERNAL 
MEDICINE) AND PATHIRASARA VIRANA POOCHU THAILAM (EXTERNAL MEDICINE ) IN 
THE TREATMENT OF SILAIPUN (VARICOSE ULCER). 
Name of Principal Investigator: Dr.Pon.Loganathan.  
                                
                                 FORM VIII – DIETARY ADVICE FORM 
 
 
     §º÷ì¸ ÜÊÂ ¯½×¸û      ¾Å¢÷ì¸ §ÅñÊÂ¨Å¸û 
 
ÓÕí¨¸ôÀ¢ïÍ 
«Å¨ÃôÀ¢ïÍ 
¸¡Ãð 
À£ðåð 
¸Ã¢º¡¨Ä 
¦À¡ýÉ¡í¸ñ½¢ 
Á½ò¾ì¸¡Ç¢              
ÓÕí¨¸ì¸£¨Ã 
Àº¨Äì¸£¨Ã 
º¢Ú¸£¨Ã                 
¸È¢§ÅôÀ¢¨Ä  
¦¸¡ò¾ÁøÄ¢ 
Á¡Ð¨Ç 
¬ôÀ¢û  
§ÀÃ£î¨º 
¾¢Ã¡ð¨º 
¦¸¡öÂ¡                
¿¡Åø 
ºô§À¡ð¼¡ 
¯Ä÷ ¾¢Ã¡ð¨º 
      §Å¸¨Åò¾ ¸¡ö¸È¢¸û 
 
§¸¡Æ¢ì¸È¢ 
Á£ý 
¿ñÎ 
¸ÕÅ¡Î 
 Óð¨¼ 
ÒÇ¢ôÒô ¦À¡Õû¸û  
§Å÷ì¸¼¨Ä 
±ûÙ 
«ýÉ¡º¢ 
¿ø¦Äñ¦½ö  
±ÖÁ¢î¨º 
¾ì¸¡Ç¢ 
ÒÇ¢ôÒ ¾Â¢÷ §Á¡÷ 
°Ú¸¡ö 
¦Àñ§À¡¸õ 
¦ÅüÈ¢¨Ä,À¡ìÌ  
Ò¨¸Â¢¨Ä  
ÁÐ «ÕóÐ¾ø  
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